Top

Phyu P Aung, M.D., Ph.D., F.CAP., F.ASCP

Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div

About Dr. Aung

I am a Professor of Pathology and a practicing Dermatopathologist with over 10 years of experience. My expertise as diagnostician for cutaneous tumors is nationally recognized; therefore, my opinion is often requested in challenging cases. I am also Director of Surgical Pathology Fellowship Program in our department which is the largest ACGME-accredited Fellowship Program in our institution since 2019. Prior to assuming the directorship position, I served as co-director of the fellowship. In addition, I am currently Site Director of Pathology fellowship Programs, and oversees the educational activities of rotating residents, fellows and observers (more than 40 trainees/year) in our department.

My research interest includes rare cutaneous neoplasms including acral melanoma, merkel cell carcinoma (MCC), blastic plasmacytoid dendritic cell neoplasm (BPDCN) and extramammary Paget disease, molecular advancement of diagnostic pathology and digital pathology. Our department is heavily focused on diagnostic responsibilities, and independent grant funding for early career faculty is unusual. However, with 13% of my effort dedicated to research, I have excelled in securing twelve intra- and extramural grant funding as Principal Investigator which include the Melanoma Research Alliance (MRA) covering 10% FTE. My work in cancer biology and cutaneous lesions has resulted in over 200 refereed journal publications (78 of these as first/corresponding author), 12 book chapters and over 200 poster/platform presentations at national and international conferences with a Google Scholar h index of 38. My work has been published in high-impact journals, including JAMA Oncology, Nature Communications, Modern Pathology, and Clinical Cancer Research. I am also a grant reviewer of 4 national and international societies including NIH. I serve on the editorial board and guest editor of the Journals, lead editor for Virtual Biopsy Program (VBP) from CAP, editor for Performance Improvement Program in Surgical Pathology (PIP) as well as Digital Slide Program-Dermatopathology (DPATH) from CAP and ad hoc reviewer for more than 30 journals. For all of my research accomplishment despite an 75% clinical load on the very busy Dermatopathology service, I was recognized with the Shirley Stein Scientific Endowed Research Award (which recognizes exceptional clinical research by faculty members with limited project resources) in 2020 and Early Career Faculty Research Award, Division of Pathology and Laboratory Medicine, at UT- MD Anderson Cancer Center, 2021, and American Society of Clinical Pathology (ASCP) Philip Levine Award for Outstanding Research, 2022.

With 12% of my effort dedicated to education, mentoring and administration, I have been serving as a member of Committee/Executive Committee of multiple national and international Pathology and Dermatopathology Societies including International Society of Dermatopathology (ISDP), College of American Pathology (CAP), American Society of Dermatopathology (ASDP), United States & Canadian Academy of Pathology (USCAP), Asian Society of Dermatopathology (ASD-cofounder). In addition, I have managed to carve out a national and international presence in the area of cutaneous malignancies, specifically melanoma and other rare cutaneous neoplasms by being invited to present and chair over 70 courses and seminars at national and international meetings and academic institutions in more than 30 different countries. I considered myself a very passionate teacher and has mentored >100 national and international residents, fellows and practicing physicians. I have authored 75 peer-reviewed publications and 113 abstracts with a fellow or resident as 1st author and received 8 fellow-mentor grants with my mentees. I have also mentored fellows/residents who are recipients of the Physician-in-Training Award for Best Presentation at the ASDP meetings in 2018 and 2020, the Best Oral Presentation at the 94th Annual Meeting of the Texas Society of Pathologists (TSP) in 2015 and the special Dr. Juan Rosai Award from the Latin American Pathology Foundation at the annual United States & Canadian Academy of Pathology (USCAP) in 2021. In recognition of my commitment to education and mentorship, I received the Faculty Educator Award (2021); Outstanding Faculty Mentor Award from the Interdisciplinary Translational Education and Research Training Program (2021); Faculty Excellence Award for Mentorship in Surgical Pathology (2022); Multi Year Appointment Award for Clinical Faculty (2022); UT System Regents’ Outstanding Teaching Award (2022); Arthur Purdy Stout Society Annual Prize (2022); Clinical Education Emil J. Freireich Award for Excellence in Education, GME (2023); Faculty Scholar award (2023); Distinguished Faculty Mentor Award (Clinical); Academic Mentoring Council (2023); and 2023 Academy Inductee, MD Anderson Academy of Health Science Education, MD Anderson's "Hall of Fame" for educators.

I also serve to our institution in the leadership roles; as Chair of Mid-Career Faculty Committee (MCFC) representing ~650 associate professors at MDACC, member of Academic Leadership Team (ALT) senator of faculty senate, voting member of graduate medical education committee and member of functional mentoring program.

I have excelled as a leader in all three classical spheres of academia: patient care, research, and education, as evidenced in my curriculum vitae. For all my above-mentioned accomplishments, I received early promotion to Associate Professor rank in 2019 and to Professor rank in 2014, President's Recognition of Faculty Excellence Award in 2020 and Arthur Purdy Stout Society Annual Prize from the United States and Canadian Academy of Pathology (USCAP) in 2022. More recently I received 2024 Lifetime Achievement Award from CAP recognizing not only my precise diagnoses having positively impacted patients but also my mentorship has shaped the careers of countless pathology trainees who now hold positions in esteemed institutions nationwide.

Primary Appointment

Professor, Department of Pathology, Division of Pathology-Lab Medicine Div, The University of Texas MD Anderson Cancer Center, Houston, TX

Director, Surgical Pathology Fellowship Program (with 14 fellows per year), Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Education & Training

Degree-Granting Education

2006	Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JP, Ph.D. in Molecular Pathology
2002	Bachelor of Medicine and Bachelor of Surgery, Institute of Medicine 1, Yangon (Rangoon), MM, MBBS in Medicine (MDA equivalent)

Postgraduate Training

2023-2024	CoachRICE(International Federation of Coach Certified), in partnership with Rice University’s The Doerr Institute for New Leaders, Houston, Texas
2023-2024	The APC Pathology Leadership Fellows (APLF) program, Leadership skills, The Association of Pathology Chairs (APC), Wilmington, Delaware
2023-2023	Physician Well-being Director Course, Stanford Medicine WellMD & WellPhD, Stanford, California
2023-2023	Emotional Intelligence Certificate program, Case Western Reserve Univ. Weatherhead School of Management and MD Anderson Leadership Institute, Houston, Texas
2022-2023	Apprenticeship, Improving Data Literacy, Faculty Academic Career Development Program, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2022-2023	Graduate of LEADing Others Accelerate Leadership Program, sponsored by MD Anderson's Leadership Institute, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2022-2022	Advanced Six Sigma Yellow Belt Certification Quality Improvement Program, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2022-2023	Inaugural Faculty Academic Career Development (FACD) Academy, Administrative leadership skills, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2022-2022	Leader Skills and Universal Skills for LEADing Others and Above - High Reliability, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2021-2021	Engaged Leadership Academy, College of American Pathology (CAP), Chicago, Illinois
2021-2021	The 3rd Annual Women's Sponsorship Workshop. Mentor-Protege' Program. The Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center, Houston, Texas
2021-2022	Community of Medical Education Scholars (CoMES) Program, The University of Texas Health Science Center at Houston and McGovern Medical School, Houston, Texas
2021-2021	LEAD Oral Communication: Presentation Skills for Leaders. Leadership Institute, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2021-2021	Courses for Career Development of Educators in Healthcare in Education Week, The University of MD Anderson Cancer Center, Houston, Texas
2021-2021	The Mentoring Program, The Faculty Leadership Academy, The University of MD Anderson Cancer Center, Houston, Texas
2021-2021	Graduate of LEADing Others Leadership Program, The Faculty Leadership Academy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2021-2021	LEADing at MD Anderson, the Leadership Institute, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2021-2021	LEADing with Emotional Intelligence, the Leadership Institute, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2021-2022	The Mentorship Program, The American Society for Clinical Pathology (ASCP), Chicago, Illinois
2020-2020	The Mentor Training Workshop for faculty, Gulf Coast Consortia for Quantitative Biosciences, The University of Texas MD Anderson Cancer Center, Houston, Texas
2020-2020	Engaged Leadership Academy, College of American Pathology (CAP), Chicago, Illinois
2020-2020	The 2nd Annual Women's Sponsorship Workshop. Mentor-Protege' Program. The Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center, Houston, Texas
2020-2020	Financial Bootcamp for Understanding of Health Care Industry Finances, The Faculty Leadership Academy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
2019-2019	Early Career Women Faculty Leadership Development Seminar, The Association of American Medical Colleges (AAMC), St. Louis, Missouri
2019-2021	The Mentoring Academy, United States & Canadian Academy of Pathology (USCAP), Palm Springs, California
2017-2018	Heart of Leadership of the Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center, Houston, Texas
2016-2017	Faculty Supervisory & Management Program of the Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center, Houston, Texas
2012-2014	Clinical Fellowship, Department of Dermatopathology, Boston University School of Medicine, Boston, Massachusetts
2011-2012	Chief Resident, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
2009-2012	Clinical Residency, Anatomic Pathology/Laboratory of Pathology, National Institutes of Health, Bethesda, Maryland
2008-2009	Post-doctoral Fellow, Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio
2006-2008	Post-doctoral Fellow, Department of Cancer Biology, Cleveland Clinic, Cleveland, Ohio
2003-2006	Graduate Student, Department of Molecular Pathology, Graduate School of Biomedical Sciences and School of Medicine, Hiroshima University, Hiroshima
2002-2003	Clinical Internship, Rangoon General Hospital, Rangoon Children's Hospital and Rangoon Central Women's Hospital, Rangoon

Board Certifications

2012	Anatomic Pathology by American Board of Pathology-Lifetime

Experience & Service

Academic Appointments

Associate Professor, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2019 - 2024

Assistant Professor, Department of Pathology, Division of Pathology/La Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2014 - 2019

Administrative Appointments/Responsibilities

Chair, Mid-Career Faculty Committee (MCFC), Department of Faculty Academic Affairs, Chief Academic Officer Office, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - 2024

Chair of The Stephen Vogel Award Committee, United States and Canadian Academy of Pathology (USCAP), Houston, Texas, 2022 - Present

Secretary-General (President Elect), Asian Society of Dermatopathology (ASD), Houston, Texas, 2022 - Present

Director, Surgical Pathology Fellowship Program, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2019 - Present

Site Director of Rotating Physicians, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present

Institutional Committee Activities

Member, Designed Institutional Committee, 2024 - Present

Past-Chair, Mid-Career Faculty Committee (MCFC), 2023 - 2024

Executive Committee Member, Data Governance Executive Committee, 2023 - Present

Member, Institutional Review Subcommittee, Graduate Medical Education, 2023 - Present

Chair, Mid-Career Faculty Committee (MCFC), 2022 - 2023

Team Member, Academic Leadership Team (ALT) led by Chief Academic Officer, 2022 - Present

Member, The Faculty Academic Career Development Academy, The University of Texas MD Anderson Cancer Center, 2022 - Present

Chair elect, Institutional Committee, 2021 - 2022

Senator, Faculty Senate, 2021 - Present

Committee Member, Functional Mentoring Program, 2021 - Present

Member, Education Committee, Faculty Senate, 2021 - Present

Mentor, The Mentoring Program, The Faculty Leadership Academy, 2021 - Present

Member, Mid-Career Faculty Committee (MCFC), The University of Texas MD Anderson Cancer Center, 2020 - 2024

Member, Early Career Faculty Divisional Committee, Division of Pathology/Lab Medicine, 2020 - 2022

Voting Member, Graduate Medical Education Committee, 2019 - Present

Organizer, Journal Club for Surgical/Cytopathology Fellows in Department of Pathology, 2017 - 2020

Chair-Elect Finalist and Departmental Representative, Focus on Junior Faculty (FJF) Committee, 2016 - 2020

Member, MDACC Oncologic Surgical Pathology General and Subspecialty Fellowships – Lecture Critique and Award Committee, 2016 - Present

Chair, Program Evaluation Committee (PEC) for Dermatopathology Fellowship, 2015 - 2016

Member, Clinical Competency Committee (CCC) and Program Evaluation Committee (PEC) for Dermatopathology Fellowship, 2014 - Present

Honors & Awards

	Japanese Government Scholar Award
	Best Poster Award, Hiroshima Cancer Seminar Foundation, Japan
	Best Graduate Student Award by Dean of Hiroshima University, Hiroshima University, Japan
	Scholar-in-training Award, American Association for Cancer Research (AACR)
	Best Presentation Award, Japanese Association for Metastasis Research
	Best Poster of the Session Prize, International Gastric Cancer Association
	Teacher Award, Hiroshima University School of Medicine
	Arthur Purdy Stout Society (APSS) of Surgical Pathologists Study Stipend
	First prize of Papanicolaou Society of Cytopathology (PSC) resident research award
	Institutional Research Funding Award, The University of Texas MD Anderson Cancer Center
	Mentor of the recipient of the Award for the Best Oral Presentation (Dr. Laurence Feldmeyer), The 94th Annual Meeting of the Texas Society of Pathologists (TSP)
	Mentor of the recipient of the Physician-in-Training Award for Best Poster Presentation (Dr Maya Farah), Annual Meeting of American Society of Dermatopathology (ASDP)
	Mentored Fellow Research Grant (Dr. Dinesh Pradhan) (Competitively selected by the review committee), Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
	Department Chair Funds for Mentored Trainee Research (Dr. Nisha Ramani) (Competitively selected by the review committee), Department of Pathology, The University of Texas MD Anderson Cancer Center
	Representative to the Association of American Medical Colleges (AAMC) Early Career Women Faculty Leadership Development Seminar, competitively selected by AAMC Application Selection Committee
	Mentored Fellow Research Grant (Dr. Michael Zaleski) (Competitively selected by the review committee), Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
	Department Chair Funds for Mentored Trainee Research (Dr. Woo Cheal Cho), Department of Pathology (Competitively selected by the review committee), The University of Texas MD Anderson Cancer Center
	Young Investigator Award (YIA), Melanoma Research Alliance (MRA)
	Institutional Research Grant (IRG) Award, The University of Texas MD Anderson Cancer Center
	The 2nd Annual Women's Sponsorship Workshop. Mentor-Protege' Program The Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center. Women Leadership Network (WLN) Application Selection Committee
	Mentor of the recipient of the Physician-In-Training Award for Best Poster Presentation (Dr. Michael Occidental), Annual Meeting of American Society of Dermatopathology (ASDP)
	Mentor of the recipient of the Physician-In-Training Award for Best Platform Presentation (Dr. Katrina Collins), Annual Meeting of American Society of Dermatopathology (ASDP)
	Finalist of Early Career Faculty for Outstanding Achievement Award, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center
	Mentored Fellow Research Grant (Dr. Woo Cheal Cho) (Competitively selected by the review committee), Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
	President's Recognition of Faculty Excellence Award, The University of Texas MD Anderson Cancer Center
	The Shirley Stein Endowment Research Award
	The 3rd Annual Women's Sponsorship Workshop. Mentor-Protege' Program. The Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center. Women Leadership Network (WLN) Application Selection Committee
	Engaged Leadership Academy (ELA), Competitively Awarded by College of American Pathology (CAP) ELA Application Selection Committee
	Mentored Fellow Research Grant (Dr. Kaitlin Vanderbeck) (Competitively selected by the review committee), Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
	Faculty Educator of the quarter for the first quarter, Department of Education & Training, The University of Texas MD Anderson Cancer Center
	Early Career Faculty Research Award, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
	Department Chair Funds for Mentored Trainee Research (Dr. Kaitlin Vanderbeck), Department of Pathology (Competitively selected by the review committee), The University of Texas MD Anderson Cancer Center
	Mentor of the recipient of the special Dr. Juan Rosai Award from the Latin American Pathology Foundation (Dr. Rossana Lazcano), Annual Meeting of the United States & Canadian Academy of Pathology (USCAP)
	The American Society of Clinical Pathology (ASCP) Philip Levine Award for Outstanding Research, The American Society of Clinical Pathology (ASCP)
	Outstanding Faculty Mentor Award. Interdisciplinary Translational Education and Research Training (ITERT), The University of Texas MD Anderson Cancer Center
	Multi Year Appointment Award for Clinical Faculty, The University of Texas MD Anderson Cancer Center
	Mentor of the recipient of the Best Poster Presentation (Dr. Kaitlin Vanderbeck), The 2nd Annual Research Symposium, Division of Pathology and Laboratory Medicine (DPLM)
	Finalist, Faculty Educator of the Year, Department of Education & Training, The University of Texas MD Anderson Cancer Center
	Arthur Purdy Stout Society (APSS) Annual Prize to Recognize Significant Career Achievements in Surgical Pathology, USCAP-APSS Companion Society
	Mentor Fellow Research Grant (Dr. Yi A. Liu) (Competitively selected by the review committee) Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
	UT System Regents’ Outstanding Teaching Award, The University of Texas System
	Faculty Excellence Award for Mentorship, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
	2023 Academy Inductee, MD Anderson Academy of Health Science Education, MD Anderson’s “Hall of Fame” for educators
	UT-MD Anderson Mentoring Champion representing Division of Pathology and Lab Medicine
	Multi Year Appointment Award for Clinical Faculty (For outstanding clinical performance, excellence in research support, significant educational contributions, exemplary institutional service at MDACC, recognition as established in my field and administrative leadership in a prominent service role), The University of Texas MD Anderson Cancer Center
	Distinguished Faculty Mentor Award (Clinical), Academic Mentoring Council, The University of Texas MD Anderson Cancer Center
	Department Chair Funds for Mentored Trainee Research (Dr. Feifan Chen), Department of Pathology (Competitively selected by the review committee), The University of Texas MD Anderson Cancer Center
	Clinical Education Emil J. Freireich Award for Excellence in Education, Graduate Medical Education, The University of Texas MD Anderson Cancer Center
	Lifetime Achievement Award, The College of American Pathologists (CAP) (for my renowned support of early-career pathologists)
	Faculty Scholar Award (President's Recognition of Faculty Excellence) 2023-2026, The University of Texas MD Anderson Cancer Center

Selected Publications

Peer-Reviewed Articles

Pineda-Reyes J, Arudra SK, Aung PP, Nagarajan P, Curry JL, Tetzlaff M, Prieto VG, Wang WL, Hwu WJ, Torres-Cabala CA. Dual PD-L1/SOX10 Immunohistochemistry Combined With Digital Imaging Enhances Stratification Accuracy of Patients With Metastatic Melanoma. Am J Surg Pathol None(None):None, 2024. PMID: 39373029.
Ozkizilkaya HI, Vinocha A, Dono A, Ogunbona OB, Toruner GA, Aung PP, Kamiya Matsuoka C, Esquenazi Y, DeMonte F, Ballester LY. MTAP and p16 IHC as Markers for CDKN2A/B Loss in Meningiomas. Cancers (Basel) 16(19):None, 2024. PMID: 39409918.
Zvulunov A, Neale H, Stern J, Santaguida P, Stein AB, Koh M, Eichenfield LF, Guitart J, Goebeler M, Scarisbrick J, Willemze R, Coughlin CC, George R, Brazzelli V, Marschalko M, Belousova I, Querfeld C, Bagot M, Szepietowski JC, Papadavid E, Quaglino P, Hoeger P, Ortiz-Romero PL, Nikolaou V, Dummer R, Aung PP, Lawley L, Morel KD, Ngan B, Wain M, Gameiro A, Lacy-Niebla RM, Pope E. Approach to Mycosis Fungoides in children: Consensus-based recommendations. J Am Acad Dermatol None(None):None, 2024. PMID: 39181404.
Kwon D, Taherian M, Milton DR, Iaeger P, Chin K, Aung PP. The Secret Life of Junior Pathologists: Challenges and Future Directions. Arch Pathol Lab Med 148(7):836-845, 2024. PMID: 37852170.
Ledesma DA, Marques-Piubelli ML, Li-Ning-Tapia E, Hudgens C, Gu J, Lazcano R, Casavilca-Zambrano S, Castillo M, Davies MA, Hwu WJ, Aung PP, Giubellino A, Curry JL, Torres-Cabala C. Apoptosis Pathway-Associated Proteins Are Frequently Expressed in Melanoma: A Study of 32 Cases With Focus on Acral Lentiginous Melanoma. Am J Dermatopathol 46(7):410-415, 2024. PMID: 38718197.
Chen F, Nagarajan P, Aung PP. Digital Papillary Adenocarcinoma: The Detection of Low-Risk Human Papillomaviruses and the BRAF p.V600E Mutation in a Subset of Cases. Dermatopathology (Basel) 11(3):177-183, 2024. PMID: 39051320.
Shehabeldin A, Rohra P, Sellen LD, Zhao J, Alqaidy D, Aramin H, Hameed N, Perez YE, Lai Z, Tong YT, Milton DR, Edgerton ME, Fuller G, Hansel D, Prieto VG, Ballester LY, Aung PP. Utility of Whole Slide Imaging for Intraoperative Consultation: Experience of a Large Academic Center. Arch Pathol Lab Med 148(6):715-721, 2024. PMID: 37756559.
Ramos, J, Aung, PP. International Medical Graduates and the Shortage of US Pathologists. Archives of pathology & laboratory medicine 148(6):735-738, 2024. PMID: 37787415.
Turcios Escobar, S, Yang, RK, Nelson, KC, Gershenwald, JE, Tawbi, H, Aung, PP, Patel, SP, Torres Cabala, CA. Utility of next-generation sequencing in the diagnosis of metastatic melanoma. Journal of cutaneous pathology 51(9):644-648, 2024. PMID: 38757469.
Dimopoulos YP, Kwon D, Milton DR, Iaeger PI, Hansel DE, Prieto VG, Chin KE, Aung PP. Assessing the Impact of the COVID-19 Pandemic on Training at the MD Anderson Cancer Center Anatomical Pathology Fellowship Program. Arch Pathol Lab Med 148(5):559-565, 2024. e-Pub 2023. PMID: 37639451.
Cho WC, Saade R, Nagarajan P, Aung PP, Milton DR, Marques-Piubelli ML, Hudgens C, Ledesma D, Nelson K, Ivan D, Zhang M, Torres-Cabala CA, Campbell M, Alhalabi O, Prieto VG, Wistuba II, Esmaeli B, Curry JL. Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin. J Cutan Pathol 51(5):360-367, 2024. PMID: 38200650.
Salem, A, Wu, Y, Albarracin, C, Middleton, LP, Kalhor, N, Peng, Y, Huang, X, Aung, PP, Chen, H, Sahin, AA, Ding, Q. A Comparative Evaluation of TRPS1 and GATA3 in adenoid cystic, secretory, and acinic cell carcinomas of the breast and salivary gland. Human Pathology 145:42-47, 2024. PMID: 38262580.
Marques-Piubelli, ML, Navarrete, J, Ledesma, D, Hudgens, CW, Segura Lazcano, R, Alani, A, Huen, A, Duvic, M, Nagarajan, P, Aung, PP, Wistuba, II, Curry, JL, Miranda, RN, Torres Cabala, CA. Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides. Cells 13(5), 2024. PMID: 38474383.
Liu YA, Aung PP, Wang Y, Ning J, Nagarajan P, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Ding Q, Cho WC. TRPS1 expression in non-melanocytic cutaneous neoplasms: an immunohistochemical analysis of 200 cases. J Pathol Transl Med 58(2):72-80, 2024. PMID: 38389280.
Wang J, Peng Y, Sun H, Aung PP, Resetkova E, Yam C, Sahin AA, Huo L, Ding Q. TRPS1 and GATA3 Expression in Invasive Breast Carcinoma With Apocrine Differentiation. Arch Pathol Lab Med 148(2):200-205, 2024. PMID: 37074839.
Liu YA, Collins K, Aung PP, Nagarajan P, Curry JL, Prieto VG, Torres-Cabala CA, Cho WC. TRPS1 expression in primary and secondary extramammary Paget diseases: An immunohistochemical analysis of 93 cases. Hum Pathol 143:5-9, 2024. PMID: 38000676.
Ronen S, McAfee JL, Curry JL, Nagarajan P, Aung PP, Ivan D, Prieto VG, Tetzlaff MT, Torres-Cabala C. Phenotypic switch in mycosis fungoides: A tertiary cancer center experience. Hum Pathol 142:27-33, 2023. PMID: 37977511.
Cass S, Cope B, Bishop AJ, Chiang YJ, Ashleigh Guadagnolo B, Farooqi A, Morrison W, Witt RG, Seervai RNH, Garden AS, Fuller CD, Goepfert RP, Ross M, Gershenwald JE, Wong M, Aung PP, Keung EZ, Mitra D. Primary tumor site for localized Merkel cell carcinoma drives different management strategies without impacting oncologic outcomes. Radiother Oncol 188:109892, 2023. e-Pub 2023. PMID: 37659660.
Small C, Mukerjee S, Jangam D, Gollapudi S, Singh K, Jaye DL, Aung PP, Querfeld C, Yao K, Chisholm KM, Pullarkat S, Wang S, Gru A, Hussaini M, George TI, Ohgami RS. Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms. Int J Lab Hematol 45(5):726-734, 2023. PMID: 37282364.
Hoffman-Hall A, Puett R, Silva JA, Chen D, Bredder A, Shevade V, Han ZY, Han KT, Aung PP, Plowe CV, Nyunt MM, Loboda TV. Comparison of deforestation and forest land use factors for malaria elimination in Myanmar. IJID Reg 8(None):75-83, 2023. PMID: 37533552.
Cho WC, Li W, Gu J, Wang WL, Ning J, Sfamenos S, Gill P, Nagarajan P, Curry JL, Lazar AJ, Prieto VG, Torres-Cabala CA, Aung PP. Telomerase reverse transcriptase immunohistochemical expression is sensitive but not specific for TERT gene amplification in acral melanoma. J Cutan Pathol 50(9):845-851, 2023. e-Pub 2023. PMID: 37400233.
Vanderbeck K, Rothrock AT, Cho WC, Nagarajan P, Aung PP, Hudgens C, Bassett RL, Ivan D, Prieto VG, Curry JL, Torres-Cabala CA. PRAME and LEF1 in Combined Deep Penetrating Nevus and Combined Blue Nevus: Utility and Pitfalls. Am J Dermatopathol 45(8):549-556, 2023. PMID: 37462205.
Cho WC, Vanderbeck K, Nagarajan P, Milton DR, Gill P, Wang WL, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Aung PP. SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma. Arch Pathol Lab Med 147(7):758-766, 2023. e-Pub 2023. PMID: 36745184.
Ohgami RS, Aung PP, Gru AA, Hussaini M, Singh K, Querfeld C, Yao K, Small C, Gollapudi S, Jaye D, Wang SA, Pullarkat S, George TI. An Analysis of the Pathologic Features of Blastic Plasmacytoid Dendritic Cell Neoplasm Based on a Comprehensive Literature Database of Cases. Arch Pathol Lab Med 147(7):837-846, 2023. e-Pub 2022. PMID: 36170615.
Marques-Piubelli ML, Seervai RNH, Mudaliar KM, Ma W, Milton DR, Wang J, Muhlbauer A, Parra ER, Solis LM, Nagarajan P, Speiser J, Hudgens C, Cho WC, Aung PP, Patel A, Pacha O, Nelson KC, Tetzlaff MT, Amaria RN, Torres-Cabala CA, Prieto VG, Wistuba II, Curry JL. Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T(H) 1 T-cells. J Cutan Pathol 50(7):661-673, 2023. e-Pub 2023. PMID: 37150813.
Loo LWJ, Chew QH, Lin SK, Yang SY, Ouyang WC, Chen CK, Park SC, Jang OJ, Park JH, Chee KY, Ding KS, Chong J, Zhang L, Li K, Zhu X, Jatchavala C, Pariwatcharakul P, Kallivayalil RA, Grover S, Avasthi A, Ansari M, Maramis MM, Aung PP, Sartorius N, Xiang YT, Tan CH, Chong MY, Park YC, Kato TA, Shinfuku N, Baldessarini RJ, Sim K. Clozapine Use for Bipolar Disorder: An Asian Psychotropic Prescription Patterns Consortium Study. J Clin Psychopharmacol 43(3):278-282, 2023. PMID: 37068038.
Cho WC, Ding Q, Wang WL, Nagarajan P, Curry JL, Torres-Cabala CA, Ivan D, Albarracin CT, Sahin A, Prieto VG, Aung PP. Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics. J Cutan Pathol 50(5):434-440, 2023. e-Pub 2023. PMID: 36808637.
Braack L, Wulandhari SA, Chanda E, Fouque F, Merle CS, Nwangwu U, Velayudhan R, Venter M, Yahouedo AG, Lines J, Aung PP, Chan K, Abeku TA, Tibenderana J, Clarke SE. Developing African arbovirus networks and capacity strengthening in arbovirus surveillance and response: findings from a virtual workshop. Parasit Vectors 16(1):129, 2023. PMID: 37059998.
Hana C, Rehman T, Park K, Carracedo Uribe C, Aung PP, Hunis B, Salzberg M, Zikria J, Hussein A. Pancreatic adverse events in patients treated with immune checkpoint inhibitors. JGH Open 7(3):204-207, 2023. PMID: 36968572.
Rothrock AT, Hameed N, Cho WC, Nagarajan P, Ivan D, Torres-Cabala CA, Prieto VG, Curry JL, Aung PP. BRAF V600E immunohistochemistry as a useful tool in the diagnosis of melanomas with ambiguous morphologies and immunophenotypes. J Cutan Pathol 50(3):223-229, 2023. e-Pub 2022. PMID: 36377266.
Lewis A, Thant AA, Aslam A, Aung PPM, Azmi S. Diagnosis and management of adrenal insufficiency. Clin Med (Lond) 23(2):115-118, 2023. PMID: 36958832.
Pemmaraju N, Kantarjian H, Sweet K, Wang E, Senapati J, Wilson NR, Konopleva M, Frankel AE, Gupta V, Mesa R, Ulrickson M, Gorak E, Bhatia S, Budak-Alpdogan T, Mason J, Garcia-Romero MT, Lopez-Santiago N, Cesarman-Maus G, Vachhani P, Lee S, Bhatt VR, Blum W, Walter RB, Bixby D, Gojo I, Duvic M, Rampal RK, de Lima M, Foran J, Fathi AT, Hall AC, Jacoby MA, Lancet J, Mannis G, Stein AS, Mims A, Rizzieri D, Olin R, Perl A, Schiller G, Shami P, Stone RM, Strickland S, Wieduwilt MJ, Daver N, Ravandi F, Vasu S, Guzman M, Roboz GJ, Khoury J, Qazilbash M, Aung PP, Cuglievan B, Madanat Y, Kharfan-Dabaja MA, Pawlowska A, Taylor J, Tallman M, Dhakal P, Lane AA. North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need. Blood 141(6):567-578, 2023. e-Pub 2022. PMID: 36399715.
Li Y, Stewart K, Han KT, Han ZY, Aung PP, Thein ZW, Htay T, Chen D, Nyunt MM, Plowe CV. Understanding Spatiotemporal Human Mobility Patterns for Malaria Control Using a Multiagent Mobility Simulation Model. Clin Infect Dis 76(3):e867-e874, 2023. PMID: 35851600.
Borkenhagen LK, Aung PP, Htay T, Thein ZW, Tin OS, Mon TS, Myint W, Bailey ES, Wanninger TG, Kandeil AM, Webby RJ, Gray GC. A cross-sectional study of avian influenza A virus in Myanmar live bird markets: Detection of a newly introduced H9N2?. Influenza Other Respir Viruses 17(2):e13111, 2023. PMID: 36843223.
Rothrock AT, Torres-Cabala CA, Milton DR, Cho WC, Nagarajan P, Vanderbeck K, Curry JL, Ivan D, Prieto VG, Aung PP. Diagnostic utility of PRAME expression by immunohistochemistry in subungual and non-subungual acral melanocytic lesions. J Cutan Pathol 49(10):859-867, 2022. e-Pub 2022. PMID: 35794643.
Rothrock AT, Truong LD, Shehabeldin A, Wong MKK, Cho WC, Nagarajan P, Vanderbeck K, Curry JL, Torres-Cabala CA, Prieto VG, Aung PP. Amyloid deposition with a granulomatous reaction in a resection specimen: A clue for a preexisting Merkel cell carcinoma (**Publication with mentoring role**). J Cutan Pathol 49(9):787-790(9):787-790, 2022. PMID: 35734844.
Farah M, Milton D, Gross ND, Nagarajan P, Gu J, Curry JL, Ivan D, Torres-Cabala CA, Myers JN, Prieto VG, Aung PP. Histopathologic Features Predictive of Metastasis and Survival in 230 Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck and Non-Head and Neck Locations: A Single-Center Retrospective Study (**Publication with mentoring role**). J Eur Acad Dermatol Venereol 36(8):1246-1255(8):1246-1255, 2022. PMID: 35426183.
Kibbi N, Owen JL, Worley B, Wang JX, Harikumar V, Downing MB, Aasi SZ, Aung PP, Barker CA, Bolotin D, Bordeaux JS, Cartee TV, Chandra S, Cho NL, Choi JN, Chung KY, Cliby WA, Dorigo O, Eisen DB, Fujisawa Y, Golda N, Halfdanarson TR, Iavazzo C, Jiang SIB, Kanitakis J, Khan A, Kim JYS, Kuzel TM, Lawrence N, Leitao MM, MacLean AB, Maher IA, Mittal BB, Nehal KS, Ozog DM, Pettaway CA, Ross JS, Rossi AM, Servaes S, Solomon MJ, Thomas VD, Tolia M, Voelzke BB, Waldman A, Wong MK, Zhou Y, Arai N, Brackett A, Ibrahim SA, Kang BY, Poon E, Alam M. Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease. JAMA Oncol 8(4):618-628(4):618-628, 2022. PMID: 35050310.
Cho WC, Gill P, Nagarajan P, Aung PP, Torres-Cabala CA, Curry JL, Ivan D, Lester L, Prieto VG. Cutaneous Lymphoid Hyperplasia With T-Cell Clonality and Monotypic Plasma Cells Secondary to a Tick Bite: A Hidden Critter and the Power of Deeper Levels. Am J Dermatopathol 44(3):226-229(3):226-229, 2022. PMID: 35050559.
Aung PP, Wimmer DB, Lester TR, Tetzlaff MT, Prieto VG. Perianal condylomata lata mimicking squamous cell carcinoma (**Publication with mentoring role**). J Cutan Pathol 49(3)(3):209-214, 2022. PMID: 33470447.
El Hussein S, Wang W, Wang SA, Loghavi S, Wang X, Qiu L, Fang H, Medeiros LJ, Aung PP, Torres Cabala C, Jorgensen JL, Pemmaraju N, Khoury JD. Blastic plasmacytoid dendritic cell neoplasm with history of myeloma and concomitant acute undifferentiated leukemia. Leuk Lymphoma 62(13):3296-3299(13):3296-3299, 2021. PMID: 34304666.
Ronen S, Al-Rohil RN, Keiser E, Jour G, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Middleton LP, Torres-Cabala CA, Gershenwald JE, Aung PP, Prieto VG. Discordance in Diagnosis of Melanocytic Lesions and Its Impact on Clinical Management (**Publication with mentoring role**). Arch Pathol Lab Med (Featured Cover Image of the Journal Issue) 145(12):1505-1522, 2021. PMID: 33577643.
Wang M, Aung PP, Prieto VG. Standardized Method for Defining a 1-mm2 Region of Interest for Calculation of Mitotic Rate on Melanoma Whole Slide Images (**Publication with mentoring role**). Arch Pathol Lab Med 145(10):1255-1263, 2021. PMID: 33417687.
Cho WC, Gill P, Aung PP, Gu J, Nagarajan P, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. The utility of digital pathology in improving the diagnostic skills of pathology trainees in commonly encountered pigmented cutaneous lesions during the COVID-19 pandemic: A single academic institution experience. Ann Diagn Pathol 54:151807, 2021. PMID: 34418768.
Collins K, Gu J, Aung PP, Nagarajan P, Curry JL, Huen A, Ivan D, Prieto VG, Tetzlaff MT, Duvic M, Miranda RN, Vega F, Torres-Cabala CA. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders? (**Publication with a mentoring role**). Virchows Arch 479(2):377-383, 2021. PMID: 33604757.
Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Nagarajan P, Curry JL, Ciurea AM, Rubin AI, Hwu WJ, Prieto VG, Aung PP. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma (**Publication with mentoring role**). Arch Pathol Lab Med 145(8):943-952, 2021. PMID: 33290520.
Cho WC, Wang WL, Milton DR, Ingram DR, Nagarajan P, Curry JL, Ivan D, Lazar AJ, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma(**Publication with mentoring role**). Arch Pathol Lab Med 145(7):842-850, 2021. PMID: 33053175.
Xu M, Tapia C, Hajjar J, Sabir S, Colen R, Nagarajan P, Aung PP, Gong J, Rodon J, Fu S, Stephen B, Roy-Chowdhuri S, Le H, Yang V, Zarifa A, Abdelsalam ME, Jhingran A, Javle M, Pant S, Carter B, Milton DR, Sun R, Karp DD, Koay EJ, Yang Y, Wistuba II, Hwu P, Meric-Bernstam F, Naing A. Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens. J Immunother Precis Oncol 4(2):45-52, 2021. e-Pub 2021. PMID: 35663531.
Kwon D, Ronen S, Giubellino A, Keiser E, Aung PP, Nagarajan P, Tetzlaff MT, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. Cutaneous adnexal carcinosarcoma: Immunohistochemical and molecular evidence of epithelial mesenchymal transition. J Cutan Pathol 4(48):526-534, 2021. PMID: 32564423.
Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Feldmeyer L, Namikawa K, Nagarajan P, Tetzlaff MT, Curry JL, Ross MI, Hwu WJ, Prieto VG, Aung PP. Prognostic significance of acral lentiginous histologic type in T1 melanoma (**Publication with mentoring role**). Mod Pathol 34(3):572-583, 2021. e-Pub 2020. PMID: 32759976.
Chin KE, Kwon D, Gan Q, Ramalingam PX, Wistuba II, Prieto VG, Aung PP. Transition From a Standard to a Hybrid On-Site and Remote Anatomic Pathology Training Model During the Coronavirus Disease 2019 (COVID-19) Pandemic (**Publication with mentoring role**). Arch Pathol Lab Med 145(1):22-31, 2021. PMID: 32937659.
Farah M, Reuben A, Spassova I, Yang RK, Kubat L, Nagarajan P, Ning J, Li W, Aung PP, Curry JL, Torres-Cabala CA, Hudgens CW, Ugurel S, Schadendorf D, Gumbs C, Little LD, Futreal A, Wistuba II, Prieto VG, Wang L, Wong MK, Wargo JA, Becker JC, Tetzlaff MT. T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma. J Invest Dermatol 140(11):2146-2156.e4, 2020. e-Pub 2020. PMID: 32304704.
Aung PP, Pemmaraju N, Torres-Cabala CA, Duvic M, Konopleva M, Khoury JD, Prieto VG. Apparent partial loss of CD123 expression in blastic plasmacytoid dendritic cell neoplasm after treatment with CD123-targeted therapy. J Dermatol 47(10):e354-e355, 2020. e-Pub 2020. PMID: 32770556.
Ramani NS, Aung PP, Gu J, Sfamenos S, Sdringola-Maranga C, Nagarajan, Tetzlaff MT, Curry JL, Ivan D, Diab A, Prieto VG, Hwu WJ, Torres-Cabala CA. TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis (**Publication with mentoring role**). Mod Pathol 33(10):2067-2074, 2020. e-Pub 2020. PMID: 32404956.
Gonzàlez-Farré M, Ronen S, Keiser E, Prieto VG, Aung PP. Three Types of Nodal Melanocytic Nevi in Sentinel Lymph Nodes of Patients with Melanoma: Pitfalls, Immunohistochemistry, and a Review of the Literature (**Publication with mentoring role**). Am J Dermatopathol 42(10):739-744, 2020. PMID: 32271206.
Vougiouklakis T, Aung PP, Vasudevaraja V, Prieto VG, Torres-Cabala CA, Sulman EP, Snuderl M, Jour G. Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors. Sci Rep 10(1):12996, 2020. PMID: 32747660.
Jenkinson HA, Aung PP, Huen A. Mycosis fungoides manifesting as a morbilliform eruption mimicking a viral exanthem. Cutis 105(6):E27-E29, 2020. PMID: 32717002.
Collins K, Prieto VG, Aung PP. Unusual Presentations of Primary and Metastatic Adenoid Cystic Carcinoma Involving the Skin (**Publication with mentoring role**). Am J Dermatopathol 42(12):967-971, 2020. PMID: 32618709.
Yildiz P, Aung PP, Milton DR, Hruska C, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala C, Prieto VG. Measurement of Tumor Thickness in Cutaneous Squamous Cell Carcinomas: Do the Different Methods Provide Better Prognostic Data? (**Publication with mentoring role**). Am J Dermatopathol 42(5):337-342, 2020. PMID: 31464719.
Chen PL, Neishaboori N, Tetzlaff MT, Chen WS, Aung PP, Curry JL, Nagarajan P, Ivan D, Hwu WJ, Prieto VG, Torres-Cabala CA. BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like Melanoma. (CME Article). Am J Dermatopathol 42(5):313-321, 2020. PMID: 32310893.
Tapia C, Aung PP, Roy-Chowdhuri S, Xu M, Ouyang F, Alshawa A, Hajjar J, Singh G, Yang V, Castillo L, Le H, Murthy R, Stephen B, Hess KR, Wistuba I, Naing A. Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors. J Immunother Cancer 8(1), 2020. PMID: 32303619.
Nagarajan P, Piao J, Ning J, Noordenbos LE, Curry JL, Torres-Cabala CA, Diwan AH, Ivan D, Aung PP, Ross MI, Royal RE, Wargo JA, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MT. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features. Mod Pathol 33(3):496-513, 2020. e-Pub 2019. PMID: 31383963.
Namikawa K, Aung PP, Milton DR, Tetzlaff MT, Torres Cabala CA, Curry JL, Nagarajan P, Ivan D, Ross MI, Gershenwald JE, Prieto VG. Correlation of tumor burden in sentinel lymph nodes with tumor burden in non-sentinel lymph nodes and survival in cutaneous melanoma (**Publication with mentoring role**). Clin Cancer Res 25(24):7585-7593, 2019. PMID: 31570567.
Pradhan D, Jour G, Milton D, Vasudevaraja V, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Long L, Ding Y, Ezhilarasan R, Sulman EP, Diab A, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma (**Publication with mentoring role**). Cancers 11(12), 2019. e-Pub 2019. PMID: 31888295.
Ruiz SJ, Al Salihi S, Prieto VG, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Torres-Cabala CA, Aung PP. Unusual cutaneous metastatic carcinoma (**Publication with mentoring role**). Ann Diagn Pathol 43:151399, 2019. PMID: 31675677.
Mejbel HA, Arudra SKC, Pradhan D, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Duose DY, Luthra R, Prieto VG, Ballester LY, Aung PP. Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity (**Publication with mentoring role**). Cancers 11(11), 2019. PMID: 31684113.
Al Salihi, S, Mejbel, HA, Prieto, V, Aung, PP. Common Cutaneous Neoplasms in Patients with Immunodeficiency: A Case Series. Journal of Immunotherapy and Precision Oncology 2(3):79-84, 2019. PMID: None.
Sukswai N, Aung PP, Yin CC, Li S, Zheng X Wang W, Wang SA, Ortega V, Lyapichev K, Alfattal R, Angelove E, Tang Z, Loghavi S, Kanagal-Shammanna R, Miranda RM, Medeiros LJ, Khoury JD. Dual Expression of TCF4 and CD123 is Highly Sensitive and Specific for Blastic Plasmacytoid Dendritic Cell Neoplasm. Am J Surg Pathol 43(10):1429-1437, 2019. PMID: 31261288.
Tetzlaff MT, Tang S, Duke T, Cabanillas ME, Zuo Z, Nagarajan P, Aung PP, Torres-Cabala CA, Duvic M, Prieto VG, Heun A, Curry JL. Lichenoid dermatitis toxicity from checkpoint inhibitor therapy: An immune-related adverse event with mycosis fungoides-like morphologic and molecular features. J Cutan Pathol 46(11):872-877, 2019. PMID: 31254410.
Aung PP, Parra ER, Barua S, Sui D, Ning J, Mino B, Ledesma DA, Curry JL, Nagarajan P, Torres-Cabala CA, Efstathiou E, Hoang A, Wong MK, Wargo JA, Lazar AJ, Rao A, Prieto VG, Wistuba I, Tetzlaff MT. B7-H3 expression in Merkel cell carcinoma-associated endothelial cells correlates with locally aggressive primary tumor features and increased vascular density. Clinical Cancer Research 25(11):3455-3467, 2019. PMID: 30808776.
Kim DH, Medeiros LJ, Aung PP, Young KH, Miranda RN, Ok CY. Mantle Cell Lymphoma Involving Skin: A Clinicopathologic Study of 37 Cases. Am J Surg Pathol 43(10):1421-1428, 2019. PMID: 31219818.
Mauzo SH, Tetzlaff MT, Milton DR, Siroy AE, Nagarajan P, Torres-Cabala CA, Ivan D, Curry JL, Hudgens CW, Wargo JA, Sahin AA, Pettaway CA, Prieto VG, Aung PP. Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy (**Publication with mentoring role**). Cancers 11(6), 2019. PMID: 31146499.
Aung PP, Sukswai N, Nejati R, Loghavi S, Chen W, Torres-Cabala CA, Yin CC, Konopleva M, Zheng X, Wang J, Tang Z, Medeiros LJ, Prieto VG, Pemmaraju N, Khoury JD. PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers 11(5), 2019. e-Pub 2019. PMID: 31109153.
Erstine EM, Tetzlaff MT, Jia X, Aung PP, Prieto VG, Funchain P, Gastman BR, Billings SD, Ko JS. Prognostic Significance of "Nonsolid" Microscopic Metastasis in Merkel Cell Carcinoma Sentinel Lymph Nodes. Am J Surg Pathol 43(7):901-919, 2019. PMID: 31094923.
Kubicki SL, Park KE, Aung PP, Duvic M. Complete Resolution of Primary Cutaneous Anaplastic Large Cell Lymphoma with Topical Imiquimod. J Drugs Dermatol 18(5):460-462, 2019. PMID: 31141854.
Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Tang G, Abdullaev Z, Pack SD, Ivan D, Prieto VG, Torres-Cabala CA. Melanoma with Loss of BAP1 Expression in Patients with No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series. Am J Dermatopathol (CME Article) 41(3):167-179, 2019. PMID: 30801340.
Jour G, Vasudevaraja V, Prieto VG, Snuderl M, Torres-Cabala CA, Al-Rohil R, Sulman EP, Ballester LY, Aung PP. BCAT1 and MIR2054: Novel methylome signature distinguishes spindle/desmoplastic melanomas from superficial malignant peripheral nerve sheath tumors (**Publication with mentoring role**). Mod Pathol 32(3):338-345, 2019. PMID: 30310175.
Konopinski JC, Danialan R, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Prieto VG, Aung PP. Melanoma coexisting with solar elastosis. Hum Pathol 84:270-274, 2019. PMID: 30359637.
Al Salihi, S, Mejbel, HA, Prieto, V, Aung, PP. Common cutaneous neoplasms in patients with immunodeficiency. Journal of Immunotherapy and Precision Oncology 2(3):79-84, 2019. PMID: None.
Saenz-Ibarra B, Huen A, Nagarajan P, Torres-Cabala CA, Prieto VG, Aung PP. From mycosis fungoides to herpetic folliculitis: The significance of deeper H&E tissue sections in dermatopathology (**Publication with mentoring role**). J Cutan Pathol 46(8):624-626, 2019. PMID: 30883857.
Ronen S, Ivan D, Torres-Cabala CA, Curry JL, Tetzlaff MT, Aung PP, Nagarajan P, Sustera S, Prieto VG. Post-Radiation Vascular Lesions of the Breast. J Cutan Pathol 46(1):52-58, 2019. PMID: 30251277.
Al Salihi S, Mejbel HA, Prieto VG, Aung PP. Common cutaneous malignancies in patients with primary and secondary immune deficiencies and literature review (**Publication with mentoring role**). Journal of Immunotherapy and Precision Oncology 2(3):79-84, 2019. PMID: None.
Yildiz P, Ronen S, Aung PP, Trinidad C, Kajoian A, Prieto VG. Extramammary Paget Disease-A Challenging Case. Am J Dermatopathol 41(11):867-868, 2019. PMID: 30807292.
Riddell M, Nakayama A, Hikita T, Mirzapourshafiyi F, Kawamura T, Pasha A, Li M, Masuzawa M, Looso M, Steinbacher T, Ebnet K, Potente M, Hirose T, Ohno S, Fleming I, Gattenhohner S, Aung PP, Phung T, Yamasaki O, Yanagi T, Umemura H, Nakayama M. aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA binding ability. Nature Communications 9(1):5357, 2018. PMID: 30559384.
Curry JL, Tetzlaff MT, Wang SA, Landon G, Alouch N, Patel SP, Nagarajan P, Gupta S, Aung PP, Devine CE, Khoury JD, Loghavi S, Prieto VG, DiNardo C, Gershenwald JE. Case report of myeloid sarcoma masquerading as in-transit metastasis at a prior melanoma site: avoiding a diagnostic pitfall. Am J Dermatopathol 40(11):831-835, 2018. PMID: 29863571.
Tang Z, Li Y, Wang W, Yin CC, Tang G, Aung PP, Hu S, Lu X, Toruner GA, Medeiros LI, Khoury JD. Genomic Aberrations Involving 12p/ETV6 Are Highly Prevalent in Blastic Plasmacytoid Dendritic Cell Neoplasms and Might Represent Early Clonal Events. Leuk Res 73:86-94, 2018. PMID: 30248580.
Aria AB, Wilmas K, Kim EJ, Aung PP, Duvic M. The development of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder at the site of a melanoma excision scar. Dermatology Online Journal 24(9), 2018. PMID: 30677830.
Kubicki SL, Welborn ME, Garg N, Aung PP, Patel AB. Granulomatous dermatitis associated with ipilimumab therapy (Ipilimumab associated granulomatous dermatitis). J Cutan Pathol 45(8):636-638, 2018. PMID: 29704281.
Al-Rohil RN, Milton DR, Nagarajan P, Curry JL, Feldmeyer L, Torres-Cabala CA, Ivan D, Prieto VG, Tetzlaff MT, Aung PP. Intratumoral and Peritumoral Lymphovascular Invasion Detected by D2-40 Immunohistochemistry Correlates with Metastasis in Primary Cutaneous Merkel Cell Carcinoma (**Publication with mentoring role**). Hum Pathol 77:98-107, 2018. PMID: 29601841.
Buchely N, Al-Rohil RN, Aung PP, Jour G, Torres-Cabala CA, Prieto VG, Ivan D. Dermal xanthomatous infiltrates after Brentuximab Vedotin therapy in mycosis fungoides with large cell transformation. J Cutan Pathol 45(9):711-715, 2018. PMID: 29806104.
Emge DA, Lewis DJ, Aung PP, Duvic M. How to Discern Folliculotropic Mycosis Fungoides From Follicular Mucinosis Using a Pediatric Case (**Publication with mentoring role**). J Cutan Med Surg 22(3):336-340, 2018. PMID: 29318909.
Mauzo SH, Milton DR, Prieto VG, Torres-Cabala CA, Wang WL, Chakravarti N, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Brown RE, Aung PP. Summary of expression of SPARC protein in cutaneous vascular neoplasms and mimickers (**Publication with mentoring role**). Ann Diagn Pathol 34:151-154, 2018. PMID: 29660567.
Saenz-Ibarra B, Prieto VG, Torres-Cabala CA, Huen A, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Coccidioidomycosis Involving Lungs and Skin: A Mimicker of Metastatic Disease (**Publication with mentoring role**). Am J Dermatopathol 40(3):e41-e43, 2018. e-Pub 2017. PMID: 28857979.
Namikawa K, contribution) AP, Milton DR, Gershenwald JE, (*equal contribution) PV. Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Cancer Medicine 7(3):583-593, 2018. PMID: 29464914.
Chan WH, Lewis DJ, Kim EJ, Aung PP, Duvic M. Generalized morphea/eosinophilic fasciitis overlap after epoxy exposure. JAAD Case Rep 4(2):175-178, 2018. PMID: 29892660.
Emge DA, Lewis DJ, Aung PP. Eosinophilic cellulitis (Well syndrome) in a patient with mycosis fungoides. (**Publication with mentoring role**). Dermatology Online Journal 24(1), 2018. PMID: 29469767.
Jour G, Aung PP, Merrill ED, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Duvic M, Miranda RN, Torres-Cabala CA. Differential expression of CCR4 in primary cutaneous gamma/delta (γ/δ) T cell lymphomas and mycosis fungoides. J Dermatol Sci 89(88-91):88-91, 2018. e-Pub 2017. PMID: 29030090.
Jour G, Andeen NK, Al-Rohil RA, Aung PP, Mehrotra M, Duose D, Hoch B, Argenyi Z, Luthra R, Wistuba II, Prieto VG. Novel enriched pathways in superficial malignant peripheral nerve sheath tumors (MPNST) and spindle/desmoplastic melanomas (SDM). J Pathol 244(1):97-106, 2018. e-Pub 2017. PMID: 28991373.
Mauzo SH, Tetzlaff MT, Nelson K, Amaria R, Patel S, Aung PP, Nagarajan P, Torres-Cabala CA, Diab A, Prieto VG, Curry JL. Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade. Int J Dermatol 58(9):1045-1052, 2017. PMID: 29152725.
Shustef E, Torres-Cabala CA, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Aung PP. Intraepithelial Melanoma in the Stomach After Treatment with Immune Checkpoint Blockade Therapy (**Publication with mentoring role**). Am J Dermatopathol 39(8):e116-e118, 2017. e-Pub 2017. PMID: 28248716.
Jour G, Aung PP, Rozas-Muñoz E, Curry JL, Prieto V, Ivan D. Intraepidermal Merkel cell carcinoma: a case series of a rare entity with clinical follow-up (**Publication with mentoring role**). J Cutan Pathol 44(8):468-470, 2017. e-Pub 2017. PMID: 28543532.
Konopinski J, Prieto VG, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala CA, Fuller GN, Aung PP. Isolated Ectopic Cutaneous Atypical Meningioma of the Scalp: Another Mimicker of Primary Adnexal Tumor (**Publication with mentoring role**). Am J Dermatopathol 39(7):545-547, 2017. e-Pub 2017. PMID: 28178009.
Aung PP, Rady PL, Nagarajan P, Ivan D, Tetzlaff MT, Curry JL, Tyring SK, Prieto VG, Torres-Cabala CA. Detection of Merkel Cell Polyoma Virus and Beta Human Papillomavirus in Multiple Eccrine Poromas in a Patient with Acute Leukemia Treated With Stem Cell Transplant. Am J Dermatopathol 39(6):489-491, 2017. e-Pub 2016. PMID: 27655121.
Valero-Torres A, Prieto VG, Nagarajan P, Torres-Cabala CA, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Metastatic Melanoma with Papillary Features: A Mimic and Possible Diagnostic Pitfall (**Publication with mentoring role**). Am J Dermatopathol 39(6):468-470, 2017. PMID: 28525424.
Pina-Oviedo S, Torres-Cabala CA, Miranda RN, Tetzlaff MT, Singh S, Rapini RP, Prieto VG, Aung PP. Concomitant Cutaneous Langerhans Cell Histiocytosis and Leukemia Cutis. (**Publication with mentoring role**). Am J Dermatopathol 39(5):388-392, 2017. e-Pub 2016. PMID: 27759701.
Nagarajan P, Curry JL, Ning J, Piao J, Torres Cabala CA, Aung PP, Ivan D, Ross MI, Levenback CF, Frumovitz M, Gershenwald JE, Davies MA, Malpica A, Prieto V, Tetzlaff MT. Tumor thickness and mitotic rate robustly predict melanoma-specific survival in patients with primary vulvar melanoma: A retrospective review of 100 cases. Clin Cancer Res 23(8):2093-2104, 2017. e-Pub 2016. PMID: 27864417.
Agbay RL, Torres-Cabala CA, Patel KP, Merril ED, Duvic M, Quesada A, Prieto VG, Aung PP, Loghavi S, Young KH, Hu S, Ferrufino-Schmidt MC, Tetzlaff M, Li S, Medeiros LJ, Miranda RN. Immunophenotypic Shifts in Primary Cutaneous γδ T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens. Am J Surg Pathol 41(4):431-445, 2017. e-Pub 2017. PMID: 28248813.
Merrill ED, Agbay R, Miranda RN, Aung PP, Tetzlaff MT, Young KH, Curry JL, Nagarajan P, Ivan D, Prieto VG, Medeiros LJ, Duvic M, Torres-Cabala CA. Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell Lymphomas. Am J Surg Pathol 41(2):204-215, 2017. e-Pub 2016. PMID: 27879514.
Tetzlaff MT, Nagarajan P, Chon S, Huen A, Diab A, Omar P, Aung PP, Torres-Cabala CA, Mays SR, Prieto VG, Curry JL. Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features. Am J Dermatopathol 39(2):121-129, 2017. PMID: 28134729.
Siroy AE, Aung PP, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Milton DR, Curry JL, Ivan D, Prieto VG. Clinical Significance of BRAF V600E Mutational Status in Capsular Nevi of Sentinel Lymph Nodes in Patients with Primary Cutaneous Melanoma (**Publication with mentoring role**). Hum Pathol 59:48-54, 2017. e-Pub 2016. PMID: 27666765.
Feldmeyer L, Hudgens CW, Ray-Lyons G, Nagarajan P, Aung PP, Curry JL, Torres-Cabala CA, Mino B, Rodriguez-Canales J, Reuben A, Chen PL, Ko JS, Billings SD, Bassett RL, Wistuba II, Cooper ZA, Prieto VG, Wargo JA, Tetzlaff MT. Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma. Clin Cancer Res 22(22):5553-5563, 2016. PMID: 27166398.
Ramani NS, Curry JL, Merrill ED, Aung PP, Prieto VG, Tetzlaff MT, Duvic M, Miranda R, Torres-Cabala C. Primary cutaneous Gamma-Delta T-cell lymphoma: An unusual case with very subtle histopathological findings. Am J Dermatopathol 38(10):e147-9, 2016. PMID: 27533072.
Al-Rohil RN, Curry JL, Torres-Cabala CA, Nagarajan P, Ivan D, Aung PP, Lyons GF, Bassett RL, Prieto VG, Tetzlaff MT. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors. Hum Pathol 53:73-81, 2016. PMID: 27004944.
Feldmeyer L, Tetzlaff M, Fox P, Nagarajan P, Curry J, Ivan D, Torres Cabala CA, Prieto VG, Aung PP. Prognostic Implication of Lymphovascular Invasion Detected by Double Immunostaining for D2-40 and MITF1 in Primary Cutaneous Melanoma. (**Publication with mentoring role**). Am J Dermatopathol 38(7):484-91, 2016. e-Pub 2015. PMID: 26675354.
Jour, G, Ivan, D, Aung, PP. Updates in Molecular Dermatopathology: from diagnostics to theranostics. Global Dermatology 3(4):352-358, 2016. PMID: None.
Feldmeyer L, Moon BS, Prieto VG, Aung PP. Role of Radiotherapy in Aggressive Digital Papillary Adenocarcinoma. (**Publication with mentoring role**). Annals of Clinical and Laboratory Science 46 (2)(2):222-4, 2016. PMID: 27098633.
Bell, D, Aung, PP, Prieto, V, Ivan, D. Next-generation sequencing reveals rare genomic alterations in aggressive digital papillary adenocarcinoma. Annals of Diagnostic Pathology 19(6):381-384, 2015. PMID: 26386519.
Bell D, Aung PP, Prieto VG, Ivan D. Next-generation sequencing reveals rare genomic alterations in aggressive digital papillary adenocarcinoma. Ann Diagn Pathol 19(6):381-4, 2015. PMID: None.
Aung PP, Ballester LY, Goldberg LJ, Bhawan J. Incidental simultaneous finding of intravascular histiocytosis and reactive angioendotheliomatosis: a case report. Am J Dermatopathol 37(5):401-4, 2015. PMID: 25503604.
Aung PP, Leone D, Feller JK, Yang S, Hernandez M, Yaar R, Singh R, Helm T, Mahalingam M. Microvessel density, lymphovascular density, and lymphovascular invasion in primary cutaneous melanoma-correlation with histopathologic prognosticators and BRAF status. Hum Pathol 46(2):304-12, 2015. e-Pub 2014. PMID: 25537974.
Aung PP, Goldberg LJ, Mahalingam M, Bhawan J. Cutaneous Myopericytoma: A Report of 3 Cases and Review of the Literature. Dermatopathology (Basel) 2(1):9-14, 2015. PMID: 27047931.
Dong Y, Richards JA, Gupta R, Aung PP, Emley A, Kluger Y, Dogra SK, Mahalingam M, Wajapeyee N. PTEN functions as a melanoma tumor suppressor by promoting host immune response. Oncogene 33(38):4632-42, 2014. PMID: 24141770.
Aung PP, Bowker B, Masterpol KS, Mahalingam M. Disseminated noninterstitial granulomatous dermatitis as a cutaneous manifestation of the preleukemic state in a patient with myelodysplasia and ulcerative colitis--apropos a case and review of the literature. Am J Dermatopathol 36(7):e117-20, 2014. PMID: 24950421.
Aung PP, Batrani M, Mirzabeigi M, Goldberg LJ. Extraocular sebaceous carcinoma in situ: report of three cases and review of the literature. J Cutan Pathol 41(7):592-6, 2014. PMID: 24666211.
Aung PP, Ballester LY, Mahalingam M. Histopathology of Keratoacanthoma Revisited: Utility of Orificial Size as a Diagnostic Adjunct. Int J Surg Pathol 22(4):316-325, 2014. e-Pub 2014. PMID: 24284133.
Aung PP, Liu YC, Ballester LY, Robbins PF, Rosenberg SA, Lee CC. Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma. Hum Pathol 45(2):259-67, 2014. PMID: 24290058.
Ballester LY, Aung PP, Lai J, Nobregal R, Wang Z, Miettinen M, Warren K, Quezado M. Expression status of IDH1 mutant and SDHB genes in adult and pediatric gliomas. International Journal of Neuropathology 2(1):17-23, 2014. PMID: None.
Aung PP, Burns SJ, Bhawan J. Lichen aureus: an unusual histopathological presentation: a case report and a review of literature. Am J Dermatopathol 36(1):e1-4, 2014. PMID: 23656907.
Aung PP, Batrani M, Yang S, Mahalingam M. Apoptosis and in situ and invasive squamous cell carcinoma in sun-exposed sites. Am J Dermatopathol 35(8):797-803, 2013. PMID: 23455334.
Alimchandani M, Lai JP, Aung PP, Khangura S, Kamal N, Gallin JI, Holland SM, Malech HL, Heller T, Miettinen M, Quezado MM. Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients. Am J Surg Pathol 37(9):1365-72, 2013. PMID: 23887163.
Lai JP, Liu YC, Alimchandani M, Liu Q, Aung PP, Matsuda K, Lee CC, Tsokos M, Hewitt S, Rushing EJ, Tamura D, Levens DL, Digiovanna JJ, Fine HA, Patronas N, Khan SG, Kleiner DE, Oberholtzer JC, Quezado MM, Kraemer KH. The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D). Acta Neuropathol Commun 1(1):4, 2013. PMID: 24252196.
Aung PP, Killian K, Poropatich CO, Linehan WM, Merino MJ. Primary neuroendocrine tumors of the kidney: morphological and molecular alterations of an uncommon malignancy. Hum Pathol 44(5):873-80, 2013. PMID: 23199527.
Ballester, L, Aung, PP, Lai, JP, Digiovanna, JJ, Abdullaev, Z, Pack, SD, Linehan, WM, Stern, JB, Pinto, PA, Lee, CR. An unusual presentation of glomeruloid hemangioma in a patient with VHL syndrome: A case report and review of literature. Open Journal of Clinical Diagnostics 3(2):63-66, 2013. PMID: None.
Timur AA, Murugesan G, Zhang L, Aung PP, Barnard J, Wang QK, Gaussem P, Silverstein RL, Bhatt DL, Kottke-Marchant K. P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease. Int J Lab Hematol 34(5):473-83, 2012. PMID: 22574824.
Lai JP, Robbins PF, Raffeld M, Aung PP, Tsokos M, Rosenberg SA, Miettinen MM, Lee CC. NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis. Mod Pathol 25(6):854-8, 2012. PMID: 22388761.
Aung PP, Sarlomo-Rikala M, Lasota J, Lai JP, Wang ZF, Miettinen M. KBA62 and PNL2: 2 new melanoma markers-immunohistochemical analysis of 1563 tumors including metastatic, desmoplastic, and mucosal melanomas and their mimics. Am J Surg Pathol 36(2):265-72, 2012. PMID: 22067329.
Sanchez JA, Krumroy L, Plummer S, Aung PP, Merkulova A, Skacel M, DeJulius KL, Manilich E, Church JM, Casey G, Kalady MF. Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer. Br J Surg 96(10):1196-204, 2009. PMID: 19787768.
Fukuyama R, Niculaita R, Ng KP, Obusez E, Sanchez J, Kalady M, Aung PP, Casey G, Sizemore N. Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription. Oncogene 27(46):6044-55, 2008. PMID: 18591935.
Koo BH, Hurskainen T, Mielke K, Aung PP, Casey G, Autio-Harmainen H, Apte SS. ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer. Int J Cancer 121(8):1710-6, 2007. PMID: 17597111.
Zhao Z, Xiao Y, Elson P, Tan H, Plummer SJ, Berk M, Aung PP, Lavery IC, Achkar JP, Li L, Casey G, Xu Y. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer. J Clin Oncol 25(19):2696-701, 2007. PMID: 17602074.
Aung PP, Oue N, Mitani Y, Nakayama H, Yoshida K, Noguchi T, Bosserhoff AK, Yasui W. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 25(17):2546-57, 2006. PMID: 16331256.
Aung PP, Mitani Y, Sanada Y, Nakayama H, Matsusaki K, Yasui W. Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas. Virchows Arch 448(4):428-34, 2006. e-Pub 2005. PMID: 16328347.
Aung PP, Matsumura S, Kuraoka K, Kunimitsu K, Yoshida K, Matsusaki K, Nakayama H, Yasui W. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population. Oncol Rep 14(5):1151-4, 2005. PMID: 16211278.
Oue N, Mitani Y, Aung PP, Sakakura C, Takeshima Y, Kaneko M, Noguchi T, Nakayama H, Yasui W. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol 207(2):185-98, 2005. PMID: 16086444.
Shutoh M, Oue N, Aung PP, Noguchi T, Kuraoka K, Nakayama H, Kawahara K, Yasui W. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation. Cancer 104(8):1609-19, 2005. PMID: 16134180.
Mizuiri H, Yoshida K, Toge T, Oue N, Aung PP, Noguchi T, Yasui W. DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage. Cancer Sci 96(9):571-7, 2005. PMID: 16128742.
Motoshita J, Oue N, Nakayama H, Kuraoka K, Aung PP, Taniyama K, Matsusaki K, Yasui W. DNA methylation profiles of differentiated-type gastric carcinomas with distinct mucin phenotypes. Cancer Sci 96(8):474-9, 2005. PMID: 16108828.
Mitani Y, Oue N, Hamai Y, Aung PP, Matsumura S, Nakayama H, Kamata N, Yasui W. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma. J Pathol 205(1):65-73, 2005. PMID: 15586362.
Yasui W, Oue N, Shuto M, Aung PP. Gene expression profiling in stomach cancer and its clinical application. Nihon Naika Gakkai Zasshi 94(1):25-30, 2005. PMID: 15685870.
Oue N, Aung PP, Mitani Y, Kuniyasu H, Nakayama H, Yasui W. Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression. Oncology 69 Suppl 1(SUPPL. 1):17-22, 2005. PMID: 16210872.
Oue, N, Hamai, Y, Mitani, Y, Matsumura, S, Oshimo, Y, Aung, PP, Kuraoka, K, Nakayama, H, Yasui, W. Gene Expression Profile of Gastric Carcinoma. Cancer Research 64(7):2397-2405, 2004. PMID: 15059891.
Bakshi N, Al Hejazi A, Mugarairi a, Alottaibi AS, Khogeer HA, Seliem RM, Pandita R, Rasian H, Aung PP, Ohgami R. A multidisciplinary approach to diagnosing blastic plasmacytoid denddritic cell neoplasm (BPDCN): Practical recommendations and insights from countries of the Gulf Cooperation Council. Critical Reviews in Oncology/Hematology None(None):None. PMID: None.

Invited Articles

Donnelly D 3rd, Aung PP, Jour G. The"-Omics" Facet of Melanoma: Heterogeneity of Genomic, Proteomic and Metabolomic Biomarkers. Semin Cancer Biol 59:165-174, 2019. PMID: 31295564.
Cho WC, Jour G, Aung PP. Role of angiogenesis in melanoma progression. Semin Cancer Biol 59:175-186, 2019. PMID: 31255774.
Trinidad C, Torres-Cabala CA, Prieto VG, Aung PP. Update on 8th-edition American Joint Committee on Cancer Classification for Merkel Cell Carcinoma and Histopathologic Parameters that Determine Prognosis (**Publication with mentoring role**). J Clin Pathol 72(5):337-340, 2019. PMID: 30636696.
Trinidad C, Prieto VG, Aung PP. Update on Staging of Cutaneous Melanoma and Pitfalls in Histologic Examination of Staging Parameters. J Clin Pathol (**Publication with mentoring role**) 72(4):265-270, 2019. PMID: 30275100.
Zorofchian S, Iqbal F, Rao M, Aung PP, Esquenazi Y, Ballester LY. Circulating Tumor DNA, microRNA, and Metabolites in Cerebrospinal Fluid as Biomarkers for Central Nervous System Malignancies. J Clin Pathol 72(4):271-280, 2019. PMID: 30467241.
Shustef E, Kazlouskaya V, Prieto VG, Ivan D, Aung PP. Cutaneous angiosarcoma: a current update. J Clin Pathol (**Publication with mentoring role**) 70(11):917-925, 2017. PMID: 28916596.
Aung PP, Nagarajan P, Prieto VG. Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance. Lab Invest 97(6):657-668, 2017. e-Pub 2017. PMID: 28240749.
Jour G, Ivan D, Aung PP. Updates in Molecular Dermatopathology: from diagnostics to theranostics. In special issue "Update in Dermatopathology". Journal of Global Dermatology (**Publication with mentoring role**) 3(4):352-358, 2016. PMID: None.
Jour G, Ivan D, Aung PP. Angiogenesis in melanoma: an update with a focus on current targeted therapies. J Clin Pathol (**Publication with mentoring role**) 69(6):472-83, 2016. e-Pub 2016. PMID: 26865640.
Mauzo SH, Ferrarotto R, Bell D, Torres-Cabala CA, Tetzlaff MT, Prieto VG, Aung PP. Molecular characteristics and potential therapeutic targets in Merkel cell carcinoma (**Publication with mentoring role**). J Clin Pathol (Featured Cover Image of the Journal Issue) 69(5):382-90, 2016. PMID: None.
Danialan R, Mutyambizi KK, Aung PP, Prieto VG, Ivan D. Challenges in the diagnosis of cutaneous adnexal tumors. J Clin Pathol 68(12):992-1002, 2015. PMID: 26602416.
Aung PP, Mutyambizi KK, Danialan R, Ivan D, Prieto VG. Differential diagnosis of heavily pigmented melanocytic lesions: Challenges and diagnostic approach. (**Publication with mentoring role**). J Clin Pathol 68(12):963-70, 2015. PMID: 26602414.

Manuals, Teaching Aids, Other Teaching Publications

Aung PP, Cunningham CR. Solitary Fibrous Tumor (**Publication with mentoring role**) PIP-A Performance Improvement Program in Surgical Pathology (CME Eligible): College of American Pathology (CAP): CME Self-Assessment Module. None, 2024.
Aung PP, Liu YA. Cutaneous neurofibroma, diffuse type (**Publication with mentoring role**). DPATH-A Dermatopathology Program (SAM eligible): College of American Pathology (CAP): SAME Self-Assessment Module. None, 2024.
Aung PP, Cunningham CR. Malignant peripheral nerve sheath tumor (**Publication with mentoring role**) PIP-C Performance Improvement Program in Surgical Pathology (CME Eligible): College of American Pathology (CAP): CME Self-Assessment Module. None, 2024.
Aung PP, Law T. Invasive Mammary Paget Disease and Ductal Carcinoma In Situ Involving Lactiferous ducts, College of American Pathologists (CAP) Surgical Pathology Committee. VBP-C Virtual Biopsy Program. None, 2023.
Aung PP, Ronen S. Spindle cell squamous cell carcinoma (**Publication with mentoring role**) PIP-B Performance Improvement Program in Surgical Pathology (CME Eligible): College of American Pathology (CAP): CME Self-Assessment Module. None, 2023.
Aung PP, Lenskaya V. Fixed drug reaction (**Publication with mentoring role**). DPATH-A Dermatopathology Program (SAM eligible): College of American Pathology (CAP): SAM Self-Assessment Module. None, 2022.
Aung PP, Lenskaya V. Lupus panniculitis (**Publication with mentoring role**). DPATH-A Dermatopathology Program (SAM eligible): College of American Pathology (CAP): SAM-Assessment Module. None, 2022.
Aung PP, Maloney N. Neurofibroma (**Publication with mentoring role**). PIP-D Performance Improvement Program in Surgical Pathology (CME eligible): College of American Pathology (CAP): CME Self-Assessment Module. None, 2022.
Aung PP, Maloney N. Elastofibroma (**Publication with mentoring role**) PIP-A Performance Improvement Program in Surgical Pathology (CME eligible): College of American Pathology (CAP): CME Self-Assessment Module. None, 2022.
Aung PP, Keiser E. Malignant melanoma (small intestine) (**Publication with mentoring role **). PIP-A Performance Improvement Program in Surgical Pathology (CME eligible), 2021.
Aung PP, Cho WC. Endocrine Mucin-producing Sweat Gland Carcinoma (**Publication with mentoring role**). VBP-C Virtual Biopsy Program in Surgical Pathology College of American Pathology (CAP): SAM Self-Assessment Module, 2021.
Aung PP, Gill P. Atypical fibroxanthoma (**Publication with mentoring role**). DPATH-A Dermatopathology Program (SAM eligible): College of American Pathology (CAP): SAM Self-Assessment Module, 2021.
Aung PP, Gill P. Atypical Fibroxanthoma (**Publication with mentoring role**). PathologyOutlines.com website, 2021.
Aung PP, Warmke L. Malignant solitary fibrous tumor (inguinal region) (**Publication with mentoring role**). PIP-A Performance Improvement Program in Surgical Pathology (CME eligible), 2021.
Aung PP. New Faculty Orientation Resource Manual, Department of Pathology, Division of Pathology and Lab Medicine. None, 2021.
Aung PP, Kojima Y. Metastatic adenocarcinoma in soft tissue of pelvis from prostate primary (**Publication with mentoring role**) PIP-C Performance improvement Program in Surgical Pathology (CME eligible): College of American Pathology (CAP). None, 2020.
Aung PP, Ronen S. Sentinel lymph node biopsy for melanoma (**Publication with mentoring role**). VBP-C Virtual Biopsy Program in Surgical Pathology (SAM eligible): College of American Pathology (CAP), 2020.
Aung PP, Lindholm K. Diffuse large B-Cell Lymphoma, NOS (Colon) (**Publication with mentoring role**). PIP-A Performance Improvement Program in Surgical Pathology (CME eligible): College of American Pathology (CAP), 2020.
Aung PP, al E. Development and implementation of hybrid training curriculum for Pathology Fellows during COVID-19 pandemic. None, 2020.
Vasa P, Aung PP. Endocrine mucin- producing sweat gland carcinoma (EMPSGC) (**Publication with mentoring role **). American Society for Clinical Pathology (ASCP) Surgical Pathology Case Study, 2020.
Aung PP, Patel VR. Lipoma (**Publication with mentoring role**). PIP-B Performance Improvement Program in Surgical Pathology (CME eligible), 2019.
Aung PP, Bah I. Mycosis Fungoides/Sezary Syndrome (**Publication with mentoring role**). HPATH-A Hematopathology Program in Surgical Pathology (SAM eligible), 2019.
Aung PP, Patel VR. Epithelioid angiosarcoma (Breast) (**Publication with mentoring role**). PIP-B Performance Improvement Program in Surgical Pathology (CME eligible): College of American Pathology (CAP). PIP-B Performance Improvement Program in Surgical Pathology (CME eligible), 2019.
Aung PP, Gan Q. Cutaneous Candida Tropicalis Infection (**Publication with mentoring role**). VBP-D Virtual Biopsy Program in Surgical Pathology (SAM eligible): College of American Pathology (CAP), 2018.

Book Chapters

Ronen S, Aung PP. Molecular Pathology of Merkel Cell Carcinoma (**Publication with mentoring role**). In: Precision Molecular Pathology of Non-Melanocytic Entities. None. Springer Publishing, None, 2022.
Ronen S, Gill P, Aung PP. Melanocytic lesions associated with germ-line mutations: familial melanoma, BAP1-deficient lesions (**Publication with mentoring role**). In: Precision Molecular Pathology of Non-Melanocytic Lesions. None. Springer Publishing, None, 2022.
Jour G, Torres-Cabala CA, Aung PP. Molecular Biomarkers applied to diagnosis, prognosis, and treatment of Melanoma Patients (**Publication with mentoring role**). In: Precision Molecular Pathology of Non-Melanocytic Lesions. None. Springer Publishing, None, 2022.
Thomas, V, Aung, PP, Rapini, RP. Dermatopathology, 309-331, 2021.
Aung PP, Thomas V, Rapini RP. Frozen Sections in Dermatopathology. In: Frozen Section in Pathology. None. Springer Nature International Publishing, 309-331, 2021.
Torres Cabala, CA, Tetzlaff, M, Nagarajan, P, Ivan, D, Curry, JL, Aung, PP, Prieto, V. Skin, 3-227, 2020.
Aung PP. Cutaneous neural lesions and Merkel cell carcinoma, part of Skin session. In: In: Oncological Surgical Pathology. None. Springer International Publishing AG, 3-227, 2020.
Pradhan, D, Aung, PP. Muscle related neoplasm, None, 2019.
Pradhan D, Aung PP. Muscle related neoplasm. In: Dermatopathology for Residents. Neoplastic Dermatopathology. Chapter 6 (**Publication with mentoring role**). None. PathPresenter Publications, None, 2019.
Ballester, L, Aung, PP, Lee, CR. The MAPK Pathway in Melanoma, 151-163, 2016.
Ivan, D, Prieto, V, Aung, PP. Use of immunohistochemical and molecular studies in the evaluation of the sebaceous neoplasms, 81-99, 2016.
Torres-Cabala CA, Aung PP, Miranda RN, Curry JL. Immunohistology and Molecular Studies of Cutaneous T-cell Lymphomas and Mimics. In: In Applied Immunohistochemistry in the Evaluation of Skin Neoplasms. None. Springer Publishing, 229-259, 2016.
Torres Cabala, CA, Aung, PP, Miranda, R, Curry, JL. Immunohistology and molecular studies of cutaneous t-cell lymphomas and mimics, 229-259, 2016.
Ballester LY, Aung PP, Lee CR. MAPK Pathway in Melanoma. In: In Genetics of Melanoma. None. Springer Publishing, 151-163, 2016.
Ivan D, Prieto VG, Aung PP. Use of Immunohistochemistry and molecular studies in the evaluation of sebaceous neoplasms. In: Applied Immunohistochemistry in the Evaluation of Skin Neoplasms. Chapter 4, 1. None. Springer International Publishing AG, 81-99, 2016.
Ivan, D, Aung, PP. Molecular Pathology of Cutaneous Adnexal Tumors, 55-80, 2015.
Ivan D, Aung PP. Molecular pathology of Cutaneous Adnexal Tumors. In: In Precision Molecular Pathology of Dermatologic Diseases. None. Springer Publishing, 55-80, 2015.
Aung, PP, Mahalingam, M. Nodular B-lymphocyte reactive patterns, 207-230, 2014.
Aung PP, Mahalingam M. Nodular B lymphocyte reactive pattern. In: In Cutaneous Hematopathology. None. Springer Publishing, 207-230, 2014.

Letters to the Editor

Ravishankar S, Nagarajan P, Curry JL, Tetzlaff MT, Ivan D, Torres-Cabala CA, Aung PP, Prieto VG. Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas. Journal of Cutaneous Pathology 43: 722-4, 2016.

Less

Selected Presentations & Talks

Local Presentations

2024. How to evaluate and report clinically significant findings in patients with Merkel cell carcinoma (post neoadjuvant therapy). Invited. The 3rd International Merkel Cell Carcinoma (MCC) Conference. Houston, Texas, US.
Weekly Faculty Conference. Conference. Houston, TX, US.
Weekly Dermatopathology Conference. Conference. Houston, TX, US.
Weekly Melanoma Multidisciplinary Conference. Conference. Houston, TX, US.
Weekly Graft versus Host Disease Multidisciplinary Conference. Conference. Houston, TX, US.

Regional Presentations

2016. Expression of SPARC Immunohistochemistry in Cutaneous Angiosarcoma and Selected Mimickers. Conference. Dallas, TX, US.
2016. Leukemia Cutis with Langerhans Cell Differentiation. Conference. Dallas, TX, US.

National Presentations

2025. Melanocytic Lesions Demystified: Practical Strategies for Accurate Diagnosis. None. 2025 Annual Meeting. Puerto Rico, MX.
2025. Dermatopathology Unraveled: Pearls and Pitfalls for Every Pathologist. None. 2025 Annual Meeting. Puerto Rico, MX.
2024. Tumor seeding following cryoablation for uveal melanoma: case report of a rare iatrogenic complication (**Presentation with mentoring role**). Poster. 61st Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, ILL, US.
2024. How to Practically Approach Challenging Cutaneous Neoplasms and Their Mimickers. Short Course. None. Annual Meeting of College of American Pathology (CAP). Las Vegas, NV, US.
2024. Practical Approach to Challenging Melanocytic Lesions, Short Course. None. 2024 American Society of Clinical Pathology (ASCP). Chicago, ILL, US.
2024. The Secret Life of Junior Pathologists: Challenges and Future Directions-Short Course. None. 2024 American Society of Clinical Pathology (ASCP). Chicago, ILL, US.
2024. A Retrospective Analysis of 144 Patients from a Single Tertiary Cancer Center-Platform Presentation (** Presentation with mentoring role**). None. 2024 USCAP Meeting. Baltimore, MD, US.
2024. Primary Femal Urethral Mucosal Melanoma: Retrospective Analysis of Clinicopathological and Molecular Features. Poster. 2024 USCAP Meeting. Baltimore, MD, US.
2024. Interesting Cases in Dermatopathology (Self-Assessment Course). None. The 27th Joint Meeting of the International Society of Dermatopathology (ISDP). San Deigo, CA, US.
2024. Development, Assessment and Performance of Advanced Deep Learning Algorithms Using HALO-AI Digital Analysis Platform in Melanocytic Lesions with Clinicopathological Correlation-Platform Presentation (**Presentation with mentoring role**). None. 2024 USCAP Meeting. Baltimore, MD, US.
2024. Protein Kinase R-like Endoplasmic Reticulum Kinase (PERK) immunoexpression and Gene Expression Profile of the Tumor Microenviroment of Acral Melanoma (**Presentation with mentoring role**). Poster. 2024 USCAP Meeting. Baltimore, MD, US.
2024. Optimizing Immunohistochemical Detection for Histologic Diagnosis of Fusariosis-Platform Presentation. None. 2024 USCAP Meeting. Baltimore, MD, US.
2023. TRPS1 May be an Effective Discriminatory Marker for Basal Cell Carcinoma and Squamous Cell Carcinoma: An Immunohistochemical Analysis of TRPS1 in Non-Melanocytic Cutaneous Neoplasms (**Presentation with mentoring role**) Platform Presentation. None. 2023 USCAP Meeting. New Orleans, LA, US.
2023. Alpha-5 Nicotinic Acetylcholine Receptor Expression in Merkel Cell Carcinoma: Possible Etiologic Roles (**Publication with mentoring role**). None. 2023 USCAP Meeting. New Orleans, LA, US.
2023. Whole Exome Sequencing of Acral Lentiginous Melanoma Reveals Novel Somatic Mutations and Potential Differences in Patients from Different Ethnicities Poster Presentation. Poster. 2023 USCAP Meeting. New Orleans, LA, US.
2023. Pilot Clinical and Transcriptomic Analysis of Male Genitourinary Melanoma Poster Presentation. Poster. 2023 USCAP Meeting. New Orleans, LA, US.
2023. Comparative Transcriptomic Analyses Distinguish Cutaneous Squamoid Eccrine Ductal Carcinomas from Low-Grade Adenosquamous Carcinomas of the Breast-Platform Presentation. None. 2023 USCAP Meeting. New Orleans, LA, US.
2023. Practical Approach to Eyelid and Conjunctival Lesions, Short Course. None. 112nd Annual Meeting of United States and Canadian Academy of Pathology (USCAP). New Orleans, LA, US.
2023. Assessing the impact of the COVID-19 pandemic on training with hybrid model at the MD Anderson Cancer anatomical pathology fellowship (**Publication with mentoring role**) Poster Presentation. Poster. 2023 USCAP Meeting. New Orleans, LA, US.
2023. Metabolomic profiling in acral melanomas reveals key metabolic pathway gene differences compared with non-acral melanomas (**Publication with mentoring role **) Poster Presentation. Poster. 2023 USCAP Meeting. New Orleans, LA, US.
2023. Primary Mucosal Melanoma of the Esophagus: Clinicopathologic and Molecular Analysis Poster Presentation. Poster. 2023 USCAP Meeting. New Orleans, LA, US.
2023. Emergency Diagnoses in Dermatopathology, Short Course. None. 112nd Annual Meeting of United States and Canadian Academy of Pathology (USCAP). New Orleans, LA, US.
2023. Vascular changes in Merkel Cell Carcinoma: prevalence, association with local VEGF expression, and prognostic implications (**Presentation with mentoring role**). None. 2023 USCAP Meeting. New Orleans, LA, US.
2022. Digital Pathology. None. The 3rd Annual Research Retreat of the Joint Center for Computational Oncology, Oden Institute for Computational Engineering and Sciences and MD Anderson Cancer Center. Austin, TX, US.
2022. Development of algorithms incorporating advanced machine learning data and dual immunohistochemical staining for the rapid detection and accurate estimation of Ki67/MART1 and SOX10/PD-L1 values in melanocytic lesions (**Presentation with mentoring role**) Platform Presentation. None. The 3rd Annual Research Retreat of the Joint Center for Computational Oncology (Oden Institute for Computational Engineering and Sciences, MD Anderson Cancer Center and Texas Advanced Computing Center). Austin, TX, US.
2022. Pitfalls and challenges in dermatopathology. None. Ohio Society of Pathologists (OSP) Fall Meeting, OH, US.
2022. BRCA1-associated protein-1 (BAP1)-inactivated melanoma arising in a pre-existing nevus with ALK fusion and low tumor mutational burden-Oral Presentation. None. 59th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2022. Key lessons learned from evaluation of challenging melanocytic lesions: a tertiary referral institutional experience (**Presentation with mentoring role**). Poster. 59th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2022. BRAF V600E immunohistochemical study as a useful tool in the diagnosis of de-differentiated metastatic melanomas. (**Presentation with mentoring role**). Poster. 59th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2022. PRAME expression in dermal scar: a potential diagnostic pitfall. (**Presentation with mentoring role**). Poster. College of American Pathologists (CAP) Annual Meeting. New Orleans, LA, US.
2022. Cutaneous Atypical Fibroxanthoma with Osteoclast-like Giant Cell, a rare but diagnostic pitfall. Poster. 59th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2022. Common Pitfalls and Mimickers in Dermatopatholog-Short Course. None. Annual Meeting of College of American Pathology (CAP). New Orleans, LA, US.
2022. Cutaneous T-cell Lymphoma with Gamma-Delta Phenotype Presenting as a Solitary Ulcerated Erythematous Mass. Poster Presentation. None. 59th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2022. Cutaneous lesions; should be scared to miss it. None. The XLI Symposium of the International Society of Dermatopathology (ISDP)-Virtual. Houston, TX, US.
2022. Assessing the Utility of Whole Slide Imaging for Intraoperative Consultation: Experience of a Large academic Center during COVID-19- Pandemic (**Presentation with mentoring role**). Poster. College of American Pathologists (CAP) Annual Meeting. New Orleans, LA, US.
2022. Pityriasis Rubra Pilaris Following Moderna COVID-19 Vaccination: A Case Report and Literature Review. Poster. 59th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2022. Expression of Nicotinic Acetylcholine Receptor in Merkel Cell Carcinoma: Its Potential Etiologic and Prognostic Role-Oral Presentation (**Presentation with mentoring role**). None. 59th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2022. Emergency Diagnoses in Dermatopathology. None. The 33rd Annual Meeting of the Brazilian Society of Pathology and 26th of the Cytopathology. Foz do Iguacu, BR.
2022. Dermatopathology for General Pathologists. None. Turkish Society of Pathology, TR.
2022. Pitfalls and challenges in melanocytic dermatopathology. None. 2022 International Society of Dermatopathology Conference. Houston, TX, US.
2022. EXPRESSION OF SPRED1 AND NF1 IN AN ACRAL LENTIGINOUS MELANOMA-ENRICHED COHORT-Platform Presentation. None. 25th Joint Meeting of the ISDP-Virtual. Houston, TX, US.
2022. Challenging cases in Dermatopathology. None. Learning from the Experience of Experts in Dermatopathology. Houston, TX, US.
2022. Practical Approach to Eyelid and Conjunctival Lesions-Short Course. None. USCAP 111th Meeting. Los Angeles, CA, US.
2022. Emergency Diagnoses in Dermatopathology, Short Course. None. USCAP 111th Meeting. Los Angeles, CA, US.
2022. SOX11 Serves as an Effective Discriminatory Marker. When Used in Conjunction with CK20 and TTF1, for Merkel Cell Carcinoma: A comparative Analysis of SOX11, CK20, PAX5, and TTF1, for Merkel Cell Carcinomas and Pulmonary Small Cell Carcinomas (**Presentation with mentoring role**). Poster. 2022 USCAP Meeting. Los Angeles, CA, US.
2022. TRPS1 Expression is Frequently Seen in Mammary and Extramammary Paget Diseases, Except for Those Arising in the Perianal Skin (**Presentation with mentoring role**). Poster. 2022 USCAP Meeting. Los Angeles, CA, US.
2022. Extramammary Post-Radiation Atypical Vascular Lesions: A Clinicopathologic Study of Eight Cases. Poster. 2022 USCAP Meeting. Los Angeles, CA, US.
2022. Characterizing the Clinicopathologic and Molecular Landscape of Acral Lentiginous Melanoma: A Retrospective Review of 331 Patients-Platform Presentation (**Presentation with mentoring role**). None. 2022 USCAP Meeting. Los Angeles, CA, US.
2022. Multi-omics analysis of digital papillary adenocarcinoma reveals upregulation of MAGEA4 and infrequent zinc finger genes rearrangements (**Presentation with mentoring role**). Poster. 2022 USCAP Meeting. Los Angeles, CA, US.
2022. PD-L1 Expression by Tumor-Associated Macrophages (TAMs) of M2 Subtype is Associated with Overall Survival in Acral Lentiginous Melanoma of Different Ethnicities-Platform Presentation (**Presentation with mentoring role**). None. 2022 USCAP Meeting. Los Angeles, CA, US.
2022. Patterns of Cutaneous Metastases of Renal Cell Carcinoma: A Clinicopathologic Study of 70 Cases. Poster. 2022 USCAP Meeting. Los Angeles, CA, US.
2022. Pathology Reporting of Melanoma and AJCC Staging. Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines Session. None. The Annual Meeting of Academy of Dermatology Association (AAD). Boston, MA, US.
2022. Diagnostic Utility of PRAME Immunohistochemistry in Subungual and Acral Melanocytic Lesions (**Presentation with a mentoring role**). Poster. 2022 USCAP Meeting. Los Angeles, CA, US.
2022. High Expression of Nectin-4 in a Subset of Adnexal Carcinomas: A potential target for enfortumab vedotin therapy. Poster. 2022 USCAP Meeting. Los Angeles, CA, US.
2022. Cutaneous Deep Fungal Infections: Retrospective Review at a Tertiary Care Cancer Center. Poster. 2022 USCAP Meeting. Lost Angeles, CA, US.
2022. Exploratory Analyses of Tumor-Infiltrating Inflammatory Cells in Male Genitourinary Melanoma. Poster. 2022 USCAP Meeting. Los Angeles, CA, US.
2022. Thymocyte selection-associated HMG-box (TOX) but not TWIST1 expression is associated with monoclonal TCR b and g chains gene rearrangements in cutaneous T-cell infiltrates-Platform Presentation. None. The United States Cutaneous Lymphoma Consortium (USCLC). Boston, MA, US.
2022. Pathology reporting of cutaneous melanoma as per current AJCC. None. he British Society for Dermatopathology (BSD). Liverpool, GB.
2021. Role of pathology reporting in management of patients with melanoma. None. The 47th Annual Meeting of Taiwanese Dermatological Association (TDA)-Virtual. Houston, TX, TW.
2021. Merkel cell carcinoma with eccrine/ductal differentiation. Poster. 58th Annual Meeting of The American Society of Dermatopathology (ASDP) Virtual Meeting. Chicago, IL, US.
2021. Tenosynovial giant cell tumor mimicking metastatic melanoma. Poster Presentation (**Presentation with mentoring role**). None. 58th Annual Meeting of The American Society of Dermatopathology (ASDP) Virtual Meeting. Houston, TX, US.
2021. TERT Immunohistochemistry Expression as a Surrogate of TERT Promoter Mutations in Infiltrating Gliomas. Poster. 2021 Annual Meeting of American Society of Clinical Pathology (ASCP). Chicago, IL, US.
2021. Amyloid deposition with granulomatous reaction as a clue for a preexisting Merkel cell carcinoma (**Presentation with mentoring role**). Poster. 58th Annual Meeting of The American Society of Dermatopathology (ASDP) Virtual Meeting. Houston, TX, US.
2021. Evaluation of expression of PRAME and PD-L1 by immunohistochemistry among male genitourinary melanomas. Poster. 58th Annual Meeting of The American Society of Dermatopathology (ASDP) Virtual Meeting. Chicago, IL, US.
2021. Histomorphologic alterations in melanoma after combination BRAF and MEK inhibitor therapy-Platform Presentation. None. 58th Annual Meeting of The American Society of Dermatopathology (ASDP) Virtual Meeting. Chicago, IL, US.
2021. Expression of apoptosis pathway-associated proteins in Acral Lentiginous Melanoma (ALM). Poster. 18th International Congress of the Society for Melanoma Research. New Orleans, LA, US.
2021. Personalized strategies with BCL2 family inhibitors to overcome acquired resistance to BRAF (BRAFi) and MEK (MEKi) in BRAF-mutant melanomas-Platform Presentation. None. 18th International Congress of the Society for Melanoma Research. New Orleans, LA, US.
2021. Practical approach of borderline melanocytic lesions in adults and children-Short Course. None. Annual Meeting of College of American Pathology (CAP). Chicago, IL, US.
2021. Interesting and challenging melanocytic cases. None. The 3rd Asian Society of Dermatopathology meeting. Singapore, SG.
2021. Practical Approach in Diagnosis and Biomarker of Cutaneous Melanocytic Lesions. None. Annual Convention of Philippine Society of Pathologists. Manilla, PH.
2021. Quantitative Multiplex Immunofluoresence Analysis Identifies Racial Differences in the Immune Landscape of Acral Lentiginous Melanomas in Caucasian and Hispanic Patients-Platform Presentation (**Presentation with mentoring role**). None. 2021 DPLM-Research Symposium-Virtual Meeting. Houston, TX, US.
2021. Cutaneous Lesions Associated with Multinucleated Giant Cells. None. Annual Convention of Philippine Society of Pathologists. Manilla, PH.
2021. Pitfall in evaluating and reporting melanocytic lesion based on Updated CAP Protocol of Melanoma. None. Annual Convention of Philippine Society of Pathologists. Manilla, PH.
2021. Influence of Assay Conditions on Beta-Catenin Immunohistochemistry in Desmoid Fibromatosis: A Multi-Institutional Study. Poster. 2021 USCAP Virtual Meeting. Houston, TX, US.
2021. MicroRNA Expression Signature Differentiates Primary Lentiginous from Non-Lentiginous Acral Melanoma (**Presentation with mentoring role**). Poster. 2021 USCAP Virtual Meeting. Houston, TX, US.
2021. Characterization of the Immune Landscape of Acral Lentiginous Melanomas in Caucasian and Hispanic Populations-Platform Presentation (**Presentation with mentoring role**). None. 2021 USCAP Virtual Meeting. Houston, TX, US.
2021. Characterizing the Molecular Landscape of Acral Lentiginous Melanoma: A Multi-National Study of 429 patients: Stowell-Orbison/Surgical Pathology/Autopsy Award Poster (**Publication with mentoring role**). None. 2021 USCAP Virtual Meeting. Houston, TX, US.
2021. Exploratory Transcriptomic Analyses of Tumor and Microenvironment Signatures in Aggressive Digital Papillary Adenocarcinoma. Presentation: Stowell-Orbison/Surgical Pathology/Autopsy Award Poster (**Publication with mentoring role**). Poster. 2021 USCAP Virtual Meeting. Houston, TX, US.
2021. Squamoid Eccrine Ductal Carcinoma: A Clinicopathologic and Transcriptomic Profiling. Poster. 2021 USCAP Virtual Meeting. Houston, TX, US.
2021. Phenotypic Switch in Mycosis Fungoides: A Tertiary Cancer Center Experience-Platform Presentation. None. 2021 USCAP Virtual Meeting. Houston, TX, US.
2021. The Utility of Digital Pathology in Improving Diagnostic Skills of Pathology Trainees in Commonly Encountered Pigmented Cutaneous Lesions during the COVID-19 Pandemic: A Single Academic Institution Experience. Poster. 2021 USCAP Virtual Meeting. Houston, TX, US.
2021. The Utility of Telomerase Reverse Transcriptase Immunohistochemistry as a Surrogate Marker of TERT Gene Amplification Status in Acral Lentiginous Melanoma. Stowell-Orbison/Surgical Pathology/Autopsy Award Poster Presentation (**Presentation with mentoring role**). Poster. 2021 USCAP Virtual Meeting. Houston, TX, US.
2021. Transition from a Standard to a Hybrid On-Site and Remote Anatomic Pathology Training Model during the COVID-19 Pandemic. Presentation (** Presentation with mentoring role**). Conference. The UT System Shine Academy-Innovations Conference 2021 Virtual Annual Meeting. Austin, TX, US.
2020. Prognostic model for T-categorization of primary male genitourinary melanoma (MGUM). Poster. 57th Annual Meeting of The American Society of Dermatopathology (ASDP), Virtual Meeting. Houston, TX, US.
2020. Localized cutaneous argyia associated with a sliver ring. Pseudo-dimorphism in cutaneous deep fungal infections. Poster. 57th Annual Meeting of The American Society of Dermatopathology (ASDP), Virtual Meeting. Houston, TX, US.
2020. Monotypic Cutaneous Lymphoid Hyperplasia Secondary to Tick Bite: A Hidden Critter and the Power of Deeper Levels. Poster. 57th Annual Meeting of The American Society of Dermatopathology (ASDP), Virtual Meeting. Houston, TX, US.
2020. Localized cutaneous argyria associated with a silver ring-Platform Presentation. None. 57th Annual Meeting of The American Society of Dermatopathology (ASDP), Virtual Meeting. Houston, TX, US.
2020. Telomerase Reverse Transcriptase Protein Expression in More Frequent in Acral Lentiginous Melanoma than in Other Types of Cutaneous Melanoma-Platform Presentation (**Presentation with mentoring role**). None. 57th Annual Meeting of The American Society of Dermatopathology (ASDP), Virtual Meeting. Houston, TX, US.
2020. Chronic Sclerodermoid Dermatosis-Associated Aggressive Cutaneous Squamous Cell Carcinomas: Report of 3 Cases. Poster. 57th Annual Meeting of The American Society of Dermatopathology (ASDP), Virtual Meeting. Houston, TX, US.
2020. Standardized method for defining a 1-mm2 region of interest for calculation of mitotic rate on melanoma whole slide images-Platform Presentation (**Presentation with mentoring role**). None. 57th Annual Meeting of The American Society of Dermatopathology (ASDP), Virtual Meeting. Houston, TX, US.
2020. Comparative epigenetic analysis of merkel cell carcinoma in association with chronic lymphocytic leukemia-Platform Presentation (**Presentation with a mentoring role**) (ASDP-2020 Physician-In-Training Award Recipient). None. 57th Annual Meeting of the American Society of Dermatopathology (ASDP), Virtual Meeting. Houston, TX, US.
2020. Practical approach of borderline melanocytic lesions in adults and children, Short Course. None. Annual Meeting of College of American Pathology (CAP). Las Vegas, NV, US.
2020. Progressive Radiation-Induced Morphea Presenting 6 Years Later in a Patient with History of Breast Cancer. None. Texas Dermatologic Society Meeting, Virtual Meeting. Houston, TX, US.
2020. Practical Approach to Challenging Melanocytic Lesions, Short Course. None. American Society of Clinical Pathology (ASCP). Austin, TX, US.
2020. The intersection of ethnicity, immune-biology and tumor mutation burden in response to checkpoint inhibitors (CPI) in advanced acral melanoma (AM). Conference. ASCO Meeting. Chicago, IL, US.
2020. Factors Associated with Patient Outcomes After Diagnosis with Invasive Melanoma: and 8-year retrospective Study of AJCC Staging and Clinical Parameters (**Presentation with mentoring role**) Oral Presentation. None. 2020 USCAP Meeting. Los Angeles, CA, US.
2020. Comparative Study of Acral Lentiginous Melanoma in patients from USA and Japan (**Presentation with mentoring role**) Stowell Orbison Poster Presentation. Poster. 2020 USCAP Meeting. Los Angeles, CA, US.
2020. TERT Amplification is involved in Progression to Metastasis of Acral Lentiginous Melanoma (**Presentation with mentoring role**). Poster. 2020 USCAP Meeting. Los Angeles, CA, US.
2020. Correlation between metastatic tumor burden in sentinel and non-sentinel lymph nodes and prognostic significance of tumor burden in sentinel nodes in 336 patients with cutaneous melanoma: a single-institution retrospective study (**Presentation with mentoring role**). Poster. 2020 USCAP Meeting. Los Angeles, CA, US.
2020. Differentially Expressed Genes in Bullous Pemphigoid Immune-related Adverse Event (BP-irAE) from Immune Checkpoint Inhibitor Therapy: Implications in the Immunopathogenic Mechanisms Driving BP-irAE Compared to de novo BP Control. Poster. 2020 USCAP Meeting. Los Angeles, CA, US.
2020. Squamoid Eccrine Ductal Carcinoma: Elucidating Histopathologic Features Correlating with Clinical Outcome. Poster. 2020 USCAP Meeting. Los Angeles, CA, US.
2020. Primary Umbilical Melanoma: A Retrospective Study of 18 Patients. Poster. 2020 USCAP Meeting. Los Angeles, CA, US.
2020. Pigmented and non-pigmented lesions of Conjunctiva. None. ASDP Companion Meeting held at the USCAP 109th Annual Meeting. Los Angeles, CA, US.
2020. Discordance in Diagnosis of Melanocytic Lesions and its Impact on Management: A Melanoma Referral Center Experience with 1718 Cases (**Presentation with mentoring role**). Poster. 2020 USCAP Meeting. Los Angeles, CA, US.
2020. Gene Expression on the Tumor Microenvironment in Acral Lentiginous Melanoma (**Presentation with mentoring role**) Stowell-Orbison Poster Presentation. Poster. 2020 USCAP Meeting. Los Angeles, CA, US.
2020. Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma (**Presentation with mentoring role**). Poster. 2020 ISDP Meeting. Los Angeles, CA, US.
2020. TERT Expression in Acral Lentiginous Melanoma (**Presentation with mentoring role**). Poster. 2020 ISDP Meeting. Denver, CO, US.
2020. Multiple phenotypic switch of CD4 and CD8 expression in mycosis fungoides (MF). Poster. 2020 ISDP Meeting. Denver, CO, US.
2020. Cutaneous metastasis of malignant mesothelioma to the head and neck (**Presentation with mentoring role**). Poster. 2020 ISDP Meeting. Denver, CO, US.
2020. Update on acral melanoma. Conference. Melanoma Research Alliance (MRA) 2020 Scientific Retreat. Washington, DC, US.
2020. Anisometric cell lipoma with loss of retinoblastoma protein expression-Platform Presentation (**Presentation with mentoring role**). None. 2020 ISDP Meeting. Denver, CO, US.
2020. Primary cutaneous adenoid cystic carcinoma of the leg (**Presentation with mentoring role**). Poster. 2020 ISDP Meeting. Denver, CO, US.
2020. Cutaneous metastasis of breast adenoid cystic carcinoma (**Presentation with mentoring role**). Poster. 2020 ISDP Meeting. Denver, CO, US.
2019. Primary Breast Cutaneous Melanoma in Women: Distinct Histopathologic Parameters of the Primary Tumor Correlate With Disease Specific Survival: A Study of 82 Patients. None. 2019 San Antonio Breast Cancer Symposium. San Antonio, TX, US.
2019. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Commonly Presents in the Setting of Prior or Concomitant Hematologic Malignancies (PCHM): Patient Characteristics and Outcomes in the Rapidly Evolving Modern Targeted Therapy Era-Platform Presentation. Conference. The 61st Annual Meeting of The American Society of Hematology (ASH). Orlando, FL, US.
2019. Is subungual location a prognostic factor for Acral Lentiginous Melanoma? Oral Presentation. None. The 56th Annual Meeting of The American Society of Dermatopathology (ASDP). San Diego, CA, US.
2019. Intradural Clear Cell Sarcoma "Melanoma of Soft Parts" Harbors EWSR1-FLI1 Fusion Transcript. Platform Presentation, (**Presentation with mentoring role**). None. The 56th Annual Meeting of The American Society of Dermatopathology (ASDP). San Diego, CA, US.
2019. Clinically Silent Male Mammary Paget Disease. Poster. The 56th Annual Meeting of The American Society of Dermatopathology (ASDP). San Diego, CA, US.
2019. Interesting cases in Dermatopathology (Self-Assessment Course). None. 2019 American Society of Dermatopathology (ASDP) Meeting. San Diego, CA, US.
2019. Practical approach of borderline melanocytic lesions in adults and children, Short Course. None. Annual Meeting of College of American Pathology (CAP). Orlando, FL, US.
2019. Update on CAP Protocol and AJCC-TNM (8th edition) Staging Parameters of Cutaneous Malignant Neoplasms Including How to Examine and Report the Clinically Relevant Histopathologic Parameters, Short Course. None. Annual Meeting of College of American Pathology (CAP). Orlando, FL, US.
2019. Ulceration and sentinel lymph node biopsy status as prognostic factors in patients with conjunctival melanoma: Implications for the American Joint Committee on Cancer (TNM) Classification. Poster. International Society of Ocular Oncology Biennial Conference. Los Angeles, CA, US.
2019. Acral lentiginous subtype is an indicator of worse survival in early stage (T1) melanoma-Platform Presentation. None. 2019 USCAP Meeting. National Harbor, MD, US.
2019. Epigenetic Regulation of Tumor Microenvironment in Spindle cell/Desmoplastic Melanomas. Poster. 2019 USCAP Meeting. National Harbor, MD, US.
2019. B7-H3 expression in Merkel cell carcinoma-associated endothelial cells correlates with locally aggressive primary tumor features and increased vascular density. Poster. 2019 USCAP Meeting. National Harbor, MD, US.
2019. Primary Mucosal Melanoma of the Uterine Cervix: Clinicopathologic and Molecular Analysis. Poster. 2019 USCAP meeting. National Harbor, MD, US.
2019. Interesting Cases in Dermatopathology (Self-Assessment Course). None. The 22nd Joint Meeting of the International Society of Dermatopathology (ISDP). Arlington, VA, US.
2019. LEF-1 and beta-catenin expression in acral lentiginous melanoma-Platform Presentation. None. The 22nd Joint Meeting of the International Society of Dermatopathology (ISDP). Arlington, VA, US.
2018. Outcomes in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Longer-Term Follow-Up Demonstrates Poor Outcomes even in Patients with Skin-Only Presentation. None. The 60th Annual Meeting of The American Society of Hematology (ASH). San Diego, CA, US.
2018. Histologic features Predictive of Metastasis and Survival in 230 Patients with Cutaneous Squamous Cell Carcinoma (SCC)-Platform Presentation (**Presentation with mentoring role**) Physician-in-Training (PIT) Award in Poster Presentation. Poster. The 55th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2018. Bilateral atypical vascular lesion arising in the setting of radiation therapy for head and neck squamous cell carcinoma-Platform Presentation (**Presentation with mentoring role**). None. 55th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2018. Practical approach of borderline melanocytic lesions in adults and children, Short Course. None. Annual Meeting of College of American Pathology (CAP). Chicago, IL, US.
2018. Melanocarcinoma, rare but diagnostic pitfall (**Presentation with mentoring role**). Poster. Chicago, IL, US.
2018. Tumor thickness correlates with regional metastasis in male genitourinary melanoma. Poster. 55th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2018. Significance of Deeper H&E Tissue Sections in Dermatopathology (**Presentation with mentoring role**). Poster. 55th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2018. Expression of B7-H3 in tumor-associated CD31+ endothelium of Merkel cell carcinoma (MCC) correlates with more aggressive features of the primary tumor. Poster. 55th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2018. Lichen Planus Related to Transforming Growth Factor Beta Inhibitor in a Patient with Metastatic Chondrosarcoma (**Presentation with mentoring role**). Poster. 55th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2018. Metastatic Carcinoma Involving the Periareolar Skin. A surprise (**Presentation with mentoring role**). Poster. 55th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2018. Prognostic significance of immunohistochemically detected Merkel cell carcinoma sentinel lymph node metastasis, Physician-in-Training (PIT) Awards for best study in Fellows' Presentation. Poster. 55th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2018. PAX8-positive mucosa melanoma arising in the female genitourinary tract. Poster. 55th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2018. Is subungual location a prognostic factor for Acral Lentiginous Melanoma? Platform Presentation. None. 55th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2018. Histophenotypic Plasticity and Genomic Alterations in Melanoma: Correlation Study by Next Generation Sequencing (NGS) (**Presentation with mentoring role**). Poster. 55th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2018. Stage at presentation to determine associations between histologic parameters of mucosal melanoma. None. 2018 American Society of Clinical Oncology. Chicago, IL, US.
2018. Interstitial Granulomatous Dermatitis: A novel toxicity from immune checkpoint blockade therapy-Platform Presentation (**Presentation with mentoring role**). None. The 21st Joint Meeting of The International Society of Dermatopathology (ISDP). San Diego, CA, US.
2018. Mycosis Fungoides manifesting as a mobiliform eruption mimicking a viral exanthem (**Presentation with mentoring role**). Poster. 2018 American Academy of Dermatology (AAD). San Diego, CA, US.
2018. Long-term Outcomes in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Poster. The 59th Annual Meeting of The American Society of Hematology (ASH). Atlanta, GA, US.
2017. Disseminated Coccidioidomycosis: a mimicker of metastatic disease (**Presentation with mentoring role**). Poster. The 54th Annual Meeting of The American Society of Dermatopathology (ASDP). Baltimore, MD, US.
2017. Extracephalic Primary Cutaneous Osteoinvasive Squamous Cell Carcinoma: A Case Series. Poster. The 54th Annual Meeting of The American Society of Dermatopathology (ASDP). Baltimore, MD, US.
2017. Lichenoid Dermatologic Toxicity from Novel Therapy using Antimicrobial Peptide LL-37 in Melanoma: A Detailed Examination of the Clinicopathologic Features (**Presentation with mentoring role**). Poster. The 54th Annual Meeting of The American Society of Dermatopathology (ASDP). Baltimore, MD, US.
2017. Correlation between phenotype and genotype in melanoma with different morphologies: A Study of 3 cases using next generation sequencing (NGS) (**Presentation with mentoring role**). Poster. The 54th Annual Meeting of The American Society of Dermatopathology (ASDP). Baltimore, MD, US.
2017. Zuska's Disease Mimicking Squamous Cell Carcinoma: A Diagnostic Challenge. Poster. The 54th Annual Meeting of The American Society of Dermatopathology (ASDP). Baltimore, MD, US.
2017. PD-L1 Protein and mRNA Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm. Poster. 2017 USCAP Meeting. San Antonio, TX, US.
2017. Expression of PD-L1 in Extramammary Paget disease: Implications for Immune-targeted Therapy. (Presentation with mentoring role). None. 2017 USCAP Meeting. San Antonio, TX, US.
2017. Primary anorectal melanoma: A retrospective analysis of 30 patients. Expression of PD-L1 in Extramammary Paget disease: Implications of Immune-targeted Therapy-Platform Presentation. None. 2017 USCAP Meeting. San Antonio, TX, US.
2017. Interesting Cases in Dermatopathology (Self-Assessment Course). None. The 20th Joint Meeting of the International Society of Dermatopathology. Orlando, FL, US.
2017. Zebras in Dermatopathology. ASDP Companion Meeting held at the 106th Annual Meeting. None. 2017 United States and Canadian Academy of Pathology (USCAP) Meeting. San Antonio, TX, US.
2017. PD-L1 expression in sebaceous carcinoma of the eyelid implicates the utility of immune checkpoint blockade. Poster. 2017 USCAP Meeting. San Antonio, TX, US.
2017. Disagreement in melanocytic lesion biopsy assessment and its impact on management: a study of 1518 cases. Poster. 2017 USCAP Meeting. San Antonio, TX, US.
2017. An assessment of copy number variations and somatic mutations in advanced melanomas by clinical next-generation sequencing. Poster. 2017 USCAP Meeting. San Antonio, TX.
2017. Primary anorectal melanoma: A retrospective analysis of 160 patients (pts)-Platform Presentation. None. The 54th Annual Meeting of The American Society of Dermatopathology (ASDP). Baltimore, MD, US.
2017. A dual PD-L1/SOX-10 immunohistochemical study combined with digital imaging enhances accuracy in stratifying metastatic melanoma patients for immune checkpoint therapy-Platform Presentation. None. 54th Annual Meeting of The American Society of Dermatopathology (ASDP). Baltimore, MD, US.
2016. Detection of Merkel cell polyoma virus and beta human papillomavirus in multiple eccrine poromas in a patient with acute leukemia treated with stem of cell transplant. Poster. The 53rd Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2016. Expression of SPARC Immunohistochemistry in Cutaneous Angiosarcoma and Mimickers-Platform Presentation (**Presentation with mentoring role**). None. The 53rd Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2016. Lymphomatoid Papulosis Type E: An Angioinvasive Lymphoproliferative Disorder with an Indolent Clinical Course. Poster. The 53rd Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2016. Leiomyosarcoma arising in pilar leiomyoma (**Presentation with mentoring role**). Poster. The 53rd Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2016. Interesting cases in Dermatopathology (Self-Assessment Course). None. 2016 American Society of Dermatopathology (ASDP) Meeting. Chicago, IL, US.
2016. Chronic Graft versus Host Disease with Dermatomal Distribution. Poster. The 53rd Annual Meeting of The American Society of Dermatopathology. Chicago, IL, US.
2016. Isolated Cutaneous Meningioma of the Scalp: Another Mimicker of Primary Adnexal Tumor (**Presentation with mentoring role**). Poster. The 53rd Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2016. Intraepithelial melanoma in the stomach after treatment with immune Checkpoint antibody blockade therapy (**Presentation with mentoring role**). Poster. The 53rd Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2016. Lymphovascular Invasion in primary cutaneous melanoma: Is there a role for immunohistochemistry?. None. Research Symposium. Boston, MA, US.
2016. The composition, density, and location of immune infiltrates correlate with survival in Merkel cell carcinoma. Poster. 2016 USCAP Meeting. Seattle, WA, US.
2016. Primary cutaneous gamma-delta T-cell lymphoma with a predominantly epidermotropic pattern. Poster. The 74th Annual Meeting, American Academy of Dermatology. Washington, DC, US.
2016. Primary Cutaneous Gamma-Delta T Cell Lymphomas Do Not Display TH2 Chemokine Expression: Significance For Diagnosis and Therapy-Platform Presentation. None. The 19th Joint Meeting, International Society of Dermatopathology (ISDP). Arlington, VA, US.
2016. Clinical Significance of BRAF/V600E Mutational Status in Capsular Nevi of Sentinel Lymph Nodes in Patients with Primary Cutaneous Melanoma (**Presentation with mentoring role**). Poster. 2016 USCAP Meeting. Seattle, WA, US.
2016. Immunodetection of mitotic figures and G2+ tumor nuclei with histone markers in stage III melanoma samples. Poster. 2016 USCAP Meeting. Seattle, WA, US.
2016. Intratumoral lymphovascular invasion detected by D2-40 correlates with metastasis in primary cutaneous Merkel cell carcinoma (**Presentation with mentoring role**). Poster. 2016 USCAP Meeting. Seattle, WA, US.
2016. Malignant Melanomas of the Vulva: retrospective analysis of histopathologic and other parameters in 40 patients-Platform Presentation. None. 2016 USCAP Meeting. Seattle, WA, US.
2016. Prognostic Significance of Regression in Patients with Thin Primary Cutaneous Melanoma. Poster. 2016 USCAP Meeting. Seattle, WA, US.
2016. The composition, density and location of immune infiltrates correlate with survival in Merkel cell carcinoma-Platform Presentation. None. The 19th Joint Meeting of The International Society of Dermatopathology (ISDP). Arlington, VA, US.
2016. Partial loss of CD123+ expression after treatment with sl-401 in patients with blastic plasmacytoid dendritic cell neoplasm-Platform Presentation. None. The 19th Joint Meeting of The International Society of Dermatopathology (ISDP). Arlington, VA, US.
2016. Interesting Cases in Dermatopathology (Self-Assessment Course). None. The 19th Joint Meeting of the International Society of Dermatopathology (ISDP). Arlington, VA, US.
2015. Melanoma coexisting with solar elastosis-A potential pitfall in the differential diagnosis between benign nevus and melanoma (**Presentation with mentoring role**). Poster. The 52nd Annual Meeting of The American Society of Dermatopathology (ASDP). San Francisco, CA, US.
2015. Langerhans Cell Differentiation In A Patient with Leukemia Cutis (**Presentation with mentoring role **). Poster. The 52nd Annual Meeting of The American Society of Dermatopathology (ASDP). San Francisco, CA, US.
2015. Loss of CD30+ expression after treatment with Brentuximub vedotin in a patient with Recurrent/Relapsed Anaplastic Large Cell Lymphoma-Platform Presentation (**Presentation with mentoring role**). None. The 52nd Annual Meeting of The American Society of Dermatopathology (ASDP). San Francisco, CA, US.
2015. Perinatal syphilitic infection mimicking an invasive epithelial malignancy (**Presentation with mentoring role**). Poster. The 52nd Annual Meeting of The American Society of Dermatopathology (ASDP). San Francisco, CA, US.
2015. Aggressive digital papillary adenocarcinoma treated with radiotherapy (**Presentation with mentoring role**). Poster. The 52nd Annual Meeting of The American Society of Dermatopathology (ASDP). San Francisco, CA, US.
2015. Lymphovascular invasion and BRAF status in primary cutaneous melanoma-is there a connection?. Poster. 2015 USCAP Meeting. Boston, MA, US.
2015. The Impact of second-opinion pathologic review on melanoma management at a tertiary cancer referral center. Poster. 2015 USCAP Meeting. Boston, MA, US.
2015. The Role of Sentinel Lymph Node Biopsy in Cutaneous Adnexal Carcinomas: The MD Anderson Experience with 348 Cases-Platform Presentation. None. 2015 USCAP Meeting. Boston, MA, US.
2015. Prognostic significance of lymphovascular invasion detected by immunostaining with D2-40 and D2-40/MITF1 in patients with cutaneous melanoma. Stowell-Orbison Poster Presentation (**Presentation with mentoring role**). Poster. 2015 USCAP Meeting. Boston, MA, US.
2015. Prognostic significance of lymphovascular invasion detected by double immunostaining with D2-40/MITF1-Platform Presentation (**Presentation with mentoring role**). None. The 94th Annual Meeting of the Texas Society of Pathologists. San Antonio, TX, US.
2014. Are multiple childhood granular cell tumors a marker for RASopathies?. Poster. The 51st Annual Meeting of the American Society of Dermatopathology (ASDP). Chicago, IL, US.
2014. Pseudoxanthoma elasticum-like change adjacent to a benign adnexal neoplasm: a histopathologic reaction pattern. Poster. The 51st Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2014. Oncogenic mutations in BRAF and PTEN as regulators of the host immune response in primary cutaneous malignant melanoma. Poster. Annual Society for Investigative Dermatology Meeting. Albuquerque, NM, US.
2014. Detection of lymphovascular invasion in primary cutaneous melanoma by H&E versus double immunostaining (D2-40 and S100)-utility and correlation with established histopathologic prognosticators and BRAF status. Poster. 2014 USCAP Annual Meeting. San Diego, CA, US.
2013. Cutaneous granulomatous dermatitis in a postcolectomy patient with idiopathic ulcerative colitis. Poster. The 50th Annual Meeting of The American Society of Dermatopathology (ASDP). Washington, DC, US.
2013. ER/PR positive epidermotropic primary cutaneous eccrine carcinoma as a cutaneous manifestation of MEN2B. Poster. The 50th Annual Meeting of The American Society of Dermatopathology (ASDP). Washington, DC, US.
2013. p75 Neurotrophin Receptor expression in Squamous Cell Carcinoma. Poster. The 50th Annual Meeting of The American Society of Dermatopathology (ASDP). Washington, DC, US.
2013. Cutaneous Leiomyomas have similar morphological and molecular alterations to uterine tumors in the Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome (HLRCC)?. Poster. 2013 USCAP Annual Meeting. Baltimore, MD, US.
2012. Overexpression of HER2/neu can be determined by a new HistoSonda probe. A comparison with traditional methods FISH, CISH, and IHC in urothelial carcinoma (UC)-Platform Presentation. None. 2012 Annual Meeting of American Society of Clinical Pathology (ASCP). Boston, MA, US.
2012. Relapsed Hairy Cell Leukemia (HCL): Cytological and Immunophenotypic Findings of an Unusual Presentation in Pleural Effusion. Poster. 2012 American Society of Clinical Pathology. Boston, MA, US.
2012. Extraocular sebaceous carcinoma in-situ arising in association with squamous intraepidermal neoplasia: Case report and review. Poster. The 49th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2012. Beta-Papillomavirus and UV-induced apoptosis in situ and invasive squamous-epithelial neoplasms-Platform Presentation. None. The 49th Annual Meeting of The American Society of Dermatopathology (ASDP). Chicago, IL, US.
2012. Squamous cell carcinoma (SCC) with pilomatrical differentiation. Poster. The 49th Annual Meeting of The American Society of Dermatopathology. Chicago, IL, US.
2012. An Unusual Presentation of Glomeruloid haemangioma in a patient with VHL syndrome: a Case report and review of literature. Poster. The 15th Joint Meeting. San Diego, CA, US.
2011. Immunophenotypic shift in mycosis fungoides. Poster. 2011 American Society of Dermatopathology Meeting. Seattle, WA, US.
2011. Use of MRI Mapping, Core Biopsies and Excisional Biopsies in a Patient with Hereditary Leiomyoma Renal Cell Cancer (HLRCC). Poster. Society for Gynecologic Investigation Meeting. Miami Beach, FL, US.
2011. Morphologic Findings in a Novel Familial Polyposis Syndrome. Poster. 2011 USCAP Meeting. San Antonio, TX, US.
2011. Potential Role of HER2/Neu as a Molecular Target in the Treatment of High Grade Urothelial Cancer. Determination of Gene Amplification by FISH, CISH and IHC. Stowell-Orbison Poster Presentation. Poster. 2011 USCAP Meeting. San Antonio, TX, US.
2011. Identification of a DNA Methylation Marker That Differentiates Malignant Mesothelioma from Reactive Mesothelial Cells on Effusion Samples. Stowell-Orbison Poster Presentation. Poster. 2011 USCAP Meeting. San Antonio, TX, US.
2009. P2RY1 Gene Polymorphisms are associated with aspirin resistance in patients with a history of myocardial infarction. Poster. ISTH 2009- XXII Congress of The International Society on Thrombosis and Hemostasis. Boston, MA, US.
2007. Podocalyxin increases the aggressive phenotype of colorectal cancer cells in vitro through its interaction with ezrin. Poster. The Annual LRI Retreat Conference. Cleveland, OH, US.
2007. Using Illumina DASL and Gene Expression Platform, development of a gene expression profile to predict disease outcome of Stage II and III colorectal cancer. Poster. The Annual LRI Retreat Conference. Cleveland, OH, US.
2007. Establishment of a gene expression profile to predict disease outcome of Stage II and II. Poster. In the Forefront of Basic and Translational Cancer Research AACR/JCR 7th Joint Conference. Waikoloa, HI, US.
2006. Development of a gene expression profile to predict disease outcome of Stage II and III colorectal cancer. Poster. The Annual LRI Retreat Conference. Cleveland, OH, US.
2005. Screening of cancer specific genes and identification of MIS as a cancer specific gene and prognostic indicator in gastric cancer. Poster. The 96th Annual Meeting of the American Association for Cancer Research. Anaheim, CA, US.
2004. Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis and carcinogenesis by serial analysis of gene expression. Poster. The 95th Annual Meeting of the American Association for Cancer Research. Orlando, FL, US.

International Presentations

2025. Dermatopathology for Every Pathologist. None. Santiago, CL.
2025. Interactive Microscopic Session for Pathology Trainees Dermatopathology. None. Boston, US.
2024. How to practically approach diagnosis of melanocytic lesion. None. 2024 Regional Congress of Dermatology. Kuala Lumpur, MY.
2024. Correlation with clinical and other findings: when dermatopathology goes beyond the microscope. None. The XXXV Congress of International Academy of Pathology (IAP)The XX. Cancun, MX.
2024. How to differentiate benign from malignant melanocytic lesion. None. Regional Congress of Dermatology 2024. Kuala Lumpur, MY.
2024. Melanoma and Melanocytoma-Webinar. None. Monthly lecture of the Asian Society of Dermatopathology Meeting (ASD)-Virtual. Taiwan, TW.
2024. How to Evaluate and Report Treatment Response After Adjuvant or Neo-Adjuvant Therapy. None. The University of Texas MD Anderson Cancer Center. Houston, US.
2024. Pitfalls in Dermatopathology. None. The 5th Asian Society of Dermatopathology (ASD). Osaka, JP.
2024. Zebra in Dermatopathology. None. The 5th Asian Society of Dermatopathology (ASD). Osaka, JP.
2023. Biomarkers in skin tumors. None. The XXXIV Latin American Society of Pathology Congress and the 50th Congress of Argentina Society of Pathology. Buenos Aires, AR.
2023. Adnexal Alchemy: A Practical Approach to Unraveling Adnexal Lesions. None. The XLII Symposium of the International Society of Dermatopathology (ISDP). Dubai, AE.
2023. Navigating the Gray Zone: A Practical Approach to Borderline Melanocytic Lesions. None. The XLII Symposium of the International Society of Dermatopathology (ISDP). Dubai, AE.
2023. Problematic melanocytic Tumors, Keynote Speaker. None. The 32th Turkish National Congress of Pathology. Antalya, TR.
2023. Pitfalls and Challenges in Dermatopathology for General Surgical Pathologists. None. The 32th Turkish National Congress of Pathology. Antalya, TR.
2023. Merkel cell carcinoma. None. The 25th World Congress of Dermatology (WCD), Expert Forum Session. Singapore, SG.
2023. Dermatologic urgency and emergency that every pathologist should know. None. The 13th Asia Pacific International Academy of Pathology (APIAP). Penang, MY.
2023. Slides Seminar of Interesting Cutaneous Lesions. None. The 13th Asia Pacific International Academy of Pathology (APIAP). Penang, MY.
2022. Mimickers of Melanocytic Lesions. None. The 4th Asian Society of Dermatopathology (ASD) meeting-Virtual. Manila, PH.
2022. Pearls and pitfalls in dermatopathology. None. XXXIV International Congress of the International Academy of Pathology (IAP). Sydney, AU.
2022. Conjunctival melanocytic and non-melanocytic lesions. None. The 33rd Annual Meeting of the Brazilian Society of Pathology and 26th of the Cytopathology. Foz do Iguacu, BR.
2022. Practical Approach of Borderline Melanocytic Lesions. None. Turkish Dermatopathology Society. Antalya, TR.
2020. Dermatopathology for General Pathologists. None. The Second Academic Meeting of the Asian Society of Dermatopathology (ASD). Kaohsiung, TW.
2020. Neoplastic Dermatopathology for General Pathologists. None. The 3rd Academic Meeting of the Asian Society of Dermatopathology (ASD). Bali, ID.
2020. Role of sentinel lymph node biopsy in patients with melanoma. None. The 79th Annual Meeting of the Japanese Cancer Association (JCA). Hiroshima, JP.
2019. Paraneoplastic syndrome. None. The First Academic Meeting of the Asian Society of Dermatopathology (ASD). New Delhi, IN.
2019. Updates on Acral lentiginous melanoma. None. The Annual Meeting of the International Academy of Pathology (IAP), Thailand Branch. Bangkok, TH.
2019. Update on CAP Protocol of Melanoma. None. The Annual meeting of the International Academy of Pathology (IAP), Thailand Branch. Bangkok, TH.
2019. Role of immunohistochemical study in melanocytic lesion. None. The Annual Meeting of the International Academy of Pathology (IAP), Thailand Branch. Bangkok, TH.
2019. Update on adnexal neoplasms. None. ISDP Regional Meeting and the Latin American Pathology Meeting. Lima, PE.
2019. Drug eruption due to targeted and immunotherapy in oncology patients; experience from the Tertiary Cancer Center. None. The XLI Symposium of the International Society of Dermatopathology (ISDP). Lisbon, PT.
2019. Melanoma Coexisting with Solar Elastosis: A Potential Pitfall in the Differential Diagnosis between Nevus and Melanoma. None. The 24th World Congress of Dermatology (WCD 2019). Milan, IT.
2018. Career Path to be a Sophisticated Pathologist. None. Autumn Annual Meeting of the Japanese Society of Pathology. Kure, JP.
2018. Inflammatory skin diseases secondary to targeted/immunotherapy. None. The XXXII Congress of the International Academy of Pathology (IAP). Dead Sea, JO.
2018. Update on melanoma based on MDACC experience. None. International Society of Dermatopathology (ISDP) XXXIX Annual Symposium. Sao Paulo, BR.
2018. Correlation of tumor burden parameters between sentinel and non-sentinel lymph nodes in patients with cutaneous melanoma. Platform Presentation. None. International sentinel node society (ISNS). Tokyo, JP.
2018. Practical approach to challenging melanocytic neoplasms. None. London Dermatopathology 8th Symposium (LDS). Kensington, GB.
2018. Challenging cutaneous neoplasms, based on UT-MDACC experience. None. The Symposium of the Romanian Society of Dermatopathology. Timisoara, RO.
2018. Multiplex Immunofluorescence (mIF) and novel computational method demonstrates co-expression of B7-H3 in tumor-associated CD31+ endothelium of Merkel cell carcinoma (MCC). Poster. 2018 USCAP Meeting. Vancouver, CA.
2018. The Prognostic Impact of Tumor Thickness by Using Different Measurement methods in Cutaneous Squamous Cell Carcinomas. Poster. 2018 USCAP Meeting. Vancouver, CA.
2018. Comparative Methylome Analysis in Cutaneous Malignant Peripheral Nerve Sheath Tumors and Spindle/Desmoplastic Melanomas (**Presentation with mentoring role**). Poster. 2018 USCAP Annual Meeting. Vancouver, CA.
2018. Expression of Neuroendocrine Markers in Sebaceous Carcinoma: A Potential Diagnostic Pitfall (**Presentation with mentoring role**). Poster. 2018 USCAP Annual Meeting. Vancouver, CA.
2018. Melanoma with loss of BAP1 expression in patients with no family history of BAP1-associated cancer susceptibility syndrome: A case series. Poster. 2018 USCAP Meeting. Vancouver, CA.
2018. Destaining-Restaining Immunostudies Combined with Whole-Slide Scanning: A Helpful Tool in Dermatopathology. Poster. 2018 USCAP Annual Meeting. Vancouver, CA.
2018. Recurrent/Persistent Nevus: A Clinical and Histologic Evaluation of Features Associated with Recurrence and Persistence of Melanocytic Nevi (**Presentation with mentoring role**). Poster. 2018 USCAP Annual Meeting. Vancouver, CA.
2018. Primary anorectal melanoma: Distinct histopathologic parameters of the primary tumor correlate with disease specific survival (DSS) depending upon the stage at presentation-Platform Presentation. None. 2018 USCAP Annual Meeting. Vancouver, CA.
2017. Regression and lymphovascular invasion: prognosis in melanoma. None. The International Society of Dermatopathology (ISDP) XXXVIII Annual Symposium. Scotland, GB.
2017. Cutaneous clues of systemic syndrome. None. The ISDP Regional Meeting and the Latin American Pathology Meeting. Cartagena de Indias, CO.
2017. Practical approach to challenging cutaneous spindle cell neoplasms. None. London Dermatopathology 7th Symposium. Kensington, GB.
2017. Merkel cell carcinoma and Cutaneous spindle cell neoplasms. None. The 10th Asia Pacific International Academy of Pathology (APIAP). Bali Nusa Dua, ID.
2016. Interesting cases in Dermatopathology. None. International Society of Dermatopathology (ISDP) XXXVII Annual Symposium. Lima, PE.
2016. Lymphovascular invasion in primary cutaneous melanoma-a prognostic marker, detected by double immunohistochemical staining. None. London Dermatopathology 6th Symposium (LDS). London, GB.
2015. Interesting Cases in Dermatopathology (Self-Assessment Course). None. International Society of Dermatopathology (ISDP) Annual Symposium. New Delhi, IN.
2015. Interesting cases in Dermatopathology (Self-Assessment Course). None. London Dermatopathology 5th Symposium (LDS). London, GB.
2013. Expression of NY-ESO, a target for adoptive cell transfer immunotherapy of metastatic melanoma, in malignant melanoma of different morphology subtypes-Platform Presentation. None. London Dermatopathology Symposium (LDS) Meeting. London, GB.
2012. P2RY1 and P2RY12 polymorphisms and residual platelet reactivity in coronary artery disease patients on aspirin. Poster. The XXV International Symposium on Technical Innovations in Laboratory Hematology. Nice, FR.
2012. Primary Neuroendocrine Tumors of the Kidney, Morphological and Molecular Alterations of an Uncommon Malignancy. Stowell-Orbison Poster Presentation. Poster. 2012 USCAP Annual Meeting. Vancouver, CA.
2012. Chronic granulomatous disease involving gastrointestinal tract (pathology study of 313 GI biopsies from 87 cases and of the GI tract in 18 autopsy cases). Stowell-Orbison Poster Presentation. Poster. 2012 USCAP Annual Meeting. Vancouver, CA.
2012. Mixed Epithelial and Stromal Tumor of Kidney: Molecular and IHC findings of a Possible New Hereditary Syndrome-Platform Presentation. None. 2012 USCAP Annual Meeting. Vancouver, CA.
2012. Expression status of IDH1 mutant and SDHB genes in adult and pediatric gliomas. Poster. 2012 USCAP Annual Meeting. Vancouver, CA.
2012. Correlation between ERG Fusion Protein and Androgen Receptor Expression in prostate Cancer, Possible role in diagnosis and therapy. Stowell Orbison Poster Presentation. Poster. 2012 USCAP Annual Meeting. Vancouver, CA.
2012. Oncogenic SULF2 protein expression is associated with pathogenesis of cirrhosis and hepatobiliary carcinoma. Poster. 2012 USCAP Annual Meeting. Vancouver, CA.
2011. Episodic Angioedema with Eosinophilia (Gleich's Syndrome) is a Cytokine-mediated, Multilineage Cell Cycling Disorder. Poster. The 7th IES Symposium-International Eosinophil Society. Quebec City, CA.
2006. Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas. Poster. The 95th Annual Meeting of Japanese Society of Pathology. Tokyo, JP.
2005. Downregulation of Claudin-18 in gastric tumor. Poster. The Annual Meeting of Japanese Association of Gastrointestinal Carcinogenesis. Kagoshima, JP.
2005. Identification of cancer associated genes in gastrointestinal tumors. Poster. The 64th Annual Meeting of Japanese Cancer Association. Sapporo, JP.
2005. DNA methylation of genes linked with retinoid signaling in gastric cancer: reduced expression of retinoid acid receptor-beta (RAR-beta), cellular retinol-binding protein 1(CRBP1), and tazarotene-induced gene 1 (TIG1) was associated with DNA methylation. Poster. The 64th Annual Meeting of Japanese Cancer Association. Sapporo, JP.
2005. Matrix metalloproteinase-10 (MMP10) is novel serum markers for gastric cancer detection and prognostic factors in patients with gastric cancer. Poster. The 64th Annual Meeting of Japanese Cancer Association. Sapporo, JP.
2005. Identification of serum markers for prognostic detection in gastrointestinal tumors based on SAGE. Poster. The 25th Annual Meeting of Japanese Association of Serum Marker of Cancer detection. Sapporo, JP.
2005. Expression and localization of RegIV in human neoplastic and non-neoplastic tissues: Expression of RegIV is associated with intestinal and neuroendocrine differentiation of gastrointestinal adenocarcinoma-Platform Presentation. None. The 64th Annual Meeting of Japanese Cancer Association. Sapporo, JP.
2005. Immunohistochemical analysis of REGIV in human neoplastic and non-neoplastic tissues. Poster. The 14th Annual Meeting of Japanese Association for Metastasis Research. Osaka, JP.
2005. Identification of MIA and MMP-10 as new prognostic markers of gastric cancer-Platform Presentation. None. The 14th Annual Meeting of Japanese Association of Metastasis Research. Osaka, JP.
2005. Identification of MIA and MMP-10 as a cancer specific gene and prognostic indicator in gastric cancer. Poster. The 6th International Gastric Cancer Progress. Yokohama, JP.
2005. DNA Methylation analysis of genes associated with retinoid signaling pathway in gastric cancer. Poster. The 6th International Gastric Cancer Congress. Yokohama, JP.
2005. DNA Methylation analysis of genes associated with retinoid signaling pathway in gastric cancer. Poster. The 94th Annual Meeting of Japanese Society of Pathology. Yokohama, JP.
2005. A single nucleotide polymorphism in the DNMT3b promoter in gastric cancer. Poster. The 94th Annual Meeting of Japanese Society of Pathology. Yokohama, JP.
2005. Screening of new biological marker of gastric cancer and identification of MIA as a cancer specific gene and prognostic indicator in gastric cancer. Poster. The 94th Annual Meeting of Japanese Society of Pathology. Yokohama, JP.
2005. Microarray analysis of genes associated with gastric cancer. Poster. The 94th Annual Meeting of Japanese Society of Pathology. Yokohama, JP.
2005. Immunohistochemical analysis of REGIV in various types of gastric cancer-Platform Presentation. None. The 94th Annual Meeting of Japanese Society of Pathology. Yokohama, JP.
2005. Immunohistochemical analysis of REGIV in human neoplastic and non-neoplastic tissue-Platform Presentation. None. The 94th Annual Meeting of Japanese Society of Pathology. Yokohama, JP.
2004. Identification of genes specifically expressed in cancer through serial analysis of gene expression. Poster. The Joint Meeting of the 14th International Symposium of the Hiroshima Cancer Seminar and The 8th Meeting of the Tottori Bioscience Promotion Foundation Cancer and Epigenetic-Basic Research and Clinical Implication. Hiroshima, JP.
2004. Accumulation of DNA methylation is associated with advanced tumor stage in gastric carcinoma. Poster. Foundation Cancer and Epigenetic-Basic Research and Clinical Implication. Hiroshima, JP.
2004. Identification of genes potentially involved in gastric carcinogenesis through serial analysis of gene expression. Poster. The 25th International Congress of the International Academy of Pathology. Brisbane, AU.
2004. Screening of new biological marker for gastric cancer-Platform Presentation. None. The 63rd Annual Meeting of Japanese Cancer Association. Fukuoka, JP.
2004. Screening of gastric cancer specific genes through serial analysis of gene expression. Poster. The 63rd Annual Meeting of Japanese Cancer Association. Fukuoka, JP.
2004. Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis and carcinogenesis by serial analysis of gene expression-Platform Presentation. None. The 15th Annual Meeting of Japanese Society of Gastroenterological Carcinogenesis. Sapporo, JP.
2004. Search for novel genes of gastric cancer through serial analysis of gene expression-Platform Presentation. None. The 3rd International Conference on Gastroenterological Carcinogenesis. Sapporo, JP.
2004. Gastric cancer associated genes-Platform Presentation. None. The 3rd International Conference on Gastroenterological Carcinogenesis. Sapporo, JP.
2004. Identification of gene involved in carcinogenesis of gastric cancer-Platform Presentation. None. The 1st Annual Conference of Japanese Society of Pathology. Hiroshima, JP.
2004. Identification of REGIV as a biological marker for gastric cancer. Poster. The 23rd Annual Meeting of Society of Molecular Pathology. Hiroshima, JP.
2004. Identification of gastric cancer specific genes. Poster. The 1st Annual Conference of Japanese Society of Pathology. Hiroshima, JP.
2004. Identification of genes and tags potentially involved in lymphatic metastasis of gastric cancer through serial analysis of gene expression. Poster. The 93rd Annual Meeting of Japanese Society of Pathology. Sapporo, JP.
2004. Identification of genes and tags potentially involved in lymphatic metastasis of gastric cancer through SAGE data analysis. Poster. The 93rd Annual Meeting of the Japanese Society of Pathology. Sapporo, JP.
2004. Expression of osteoprotegerin in human gastric carcinoma and adenomas. Poster. The 92nd Annual Meeting of Japanese Society of Pathology. Fukuoka, JP.
2004. Genes and tags associated with gastric carcinogenesis. Poster. The Tateshina Conference. Chico, JP.
2003. Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma. Poster. The 13th International symposium of the Hiroshima cancer seminar, New approach to identification of biomarkers for early cancer detection. Hiroshima, JP.
2003. A single nucleotide polymorphism in the EGF promoter is correlated with tumor progression in gastric cancer. Poster. The 62nd Annual Meeting of Japanese Cancer Association. Nagoya, JP.

Formal Peers

2023. Mistakes and Mimickers in Dermatopathology. Invited. Mistakes and Mimickers in Dermatopathology. Virtual, BR.
2022. Pitfalls and mimickers in Dermatopathology. Invited. Pitfalls and mimickers in Dermatopathology. Houston, TX, US.
2022. Practical Approach of Borderline Melanocytic Lesions. Invited. Practical Approach of Borderline Melanocytic Lesions, TR.
2022. Pathology reporting of cutaneous melanoma with emphasis on risk stratification. Invited. Pathology reporting of cutaneous melanoma with emphasis on risk stratification, US.
2019. Molecular Pathology of Melanoma. Invited. Molecular Pathology of Melanoma. Bethesda, MD, US.
2019. Role of Dermatopathologist in diagnosis, prognosis and management of patients with melanoma. Invited. Role of Dermatopathologist in diagnosis, prognosis and management of patients with melanoma. Mexico City, MX.
2017. Practical approach of cutaneous adnexal lesions. Invited. Practical approach of cutaneous adnexal lesions. Bethesda, MD, US.
2017. Update on the 8th edition of AJCC Staging template of Merkel cell carcinoma. Invited. Update on the 8th edition of AJCC Staging template of Merkel cell carcinoma.
2017. Update on AJCC Staging and CAP template in malignant cutaneous neoplasms. Invited. Update on AJCC Staging and CAP template in malignant cutaneous neoplasms.
2017. How to report cutaneous melanoma following CAP protocol and AJCC-TNM staging parameters. Invited. How to report cutaneous melanoma following CAP protocol and AJCC-TNM staging parameters. Houston, TX, US.
2016. How to report cutaneous neoplasms based on AJCC Staging and CAP template. Invited. How to report cutaneous neoplasms based on AJCC Staging and CAP template, US.
2016. Practical approach of melanocytic lesions. Invited. Practical approach of melanocytic lesions. Bethesda, MD, US.
2016. AJCC Staging & Pathology Report for Melanoma. Invited. AJCC Staging & Pathology Report for Melanoma. Houston, TX, US.
2015. CAP pathology report in melanoma and Prognostic significance of lymphovascular invasion and regression in primary cutaneous melanoma. Invited. CAP pathology report in melanoma and Prognostic significance of lymphovascular invasion and regression in primary cutaneous melanoma. Tokyo, JP.
2014. Review of Common Lesions in Dermatopathology. Invited. Review of Common Lesions in Dermatopathology. Bethesda, MD, US.
2014. Practical approach of melanocytic lesions. Invited. Practical approach of melanocytic lesions. Bethesda, MD, US.
2013. Common Inflammatory Diseases and Neoplasms of Skin. Invited. Common Inflammatory Diseases and Neoplasms of Skin. Bethesda, MD, US.

Less

Grant & Contract Support

Title:	Challenges of Pathology Fellows: Middle-child syndrome (Project with mentoring role)
Funding Source:	The University of Texas MD Anderson Cancer Center/Department of Pathology
Role:	PI

Title:	The Role of Acetylcholine Receptors in Merkel Cell Polyoma Virus-induced Merkel Cell Carcinoma from Various Ethnicities
Funding Source:	U54-NIH/NCI
Role:	Co-PI

Title:	Immunohistochemical Characterization of Trichorhinophalangeal Syndrome Type 1 (TPRS1) in Cutaneous Adnexal and Mon-Melanocytic Epithelial Neoplasms (Project with mentoring role)
Funding Source:	The University of Texas MD Anderson Cancer Center/Division of Pathology and Lab Medicine
Role:	Co-PI

Title:	Metabolomic Signature of Acral Melanoma (Project with mentoring role)
Funding Source:	The University of Texas MD Anderson Cancer Center/Department of Pathology
Role:	PI

Title:	Development of advanced machine (deep) learning algorithms to rapidly detect and accurately estimate the percentage of melanocytes expressing Mart1-Ki67 in borderline melanocytic lesions, and PDL1 in tumor cells, using double staining with tumor specific makers, Oncological Data and Computational Sciences sponsored by The Oden Institute for Computational Engineering and Sciences (Oden Institute)
Funding Source:	The University of Texas MD Anderson Cancer Center (MD Anderson), and Texas Advanced Computing Center (TACC)
Role:	PI

Title:	Molecular Characterization of Rare Cutaneous Neoplasms
Funding Source:	The Shirley Stein Endowment Research Grant
Role:	PI

Title:	Targeting a Stress-Derived Immunosuppressive Adenosine Pathway in Tumors Resistant to Checkpoint Inhibitors (W81XWH-19-1-0282-DOD Idea Award)
Funding Source:	Department of Defense (DOD)
Role:	Co-PI

Title:	Primary Acral Melanoma from Various Ethnicities: Comprehensive Molecular and Immune Profiling. Young Investigator Award
Funding Source:	Melanoma Research Alliance
Role:	PI

Title:	Development of personalized combinatorial strategies targeting apoptotic machinery in melanoma
Funding Source:	U54-NIH/NCI (5U54CA224070-03)
Role:	Co-PI

Title:	A phase 2, Open-Label Study Evaluating the Safety and Efficacy of KRT-232 in Patients with p53 Wild-Type (p53wt) Merkel Cell Carcinoma (MCC) Who Have Failed Anti-PD-1 or Anti-PD-L1 Immunotherapy, or in Combination with Avelumab in MCC Patients who are Anti-PD-1 or Anti-PD-L1 Treatment Naive, KRT-232-103
Funding Source:	Funded by Kartos Therapeutics, Inc
Role:	Collaborator

Title:	Phase 2 Clinical Trial for Comprehensive Treatment Program for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Tagraxofusp (SL-401) in Combination with HCVAD/Mini-CVD and VENETOCLAX
Funding Source:	Funded by APOLLO
Role:	Collaborator

Title:	A Study to evaluate patient samples with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Funding Source:	Funded by Stemline
Role:	Collaborator

Title:	A phase 1, open-label, dose escalation study of pf-04518600 as a single agent and in combination with pf-05082566 in patients with selected locally advanced or metastatic carcinomas
Funding Source:	Funded by Pfizer biopharmaceutical companies
Role:	Collaborator

Title:	Investigation of the biology of tumor angiogenesis, H-33324
Funding Source:	Funded by Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Collaborator

Title:	LGX818/MEK162 combination followed by a rational combination with targeted agents after progression
Funding Source:	Funded by Array BioPharma
Role:	Collaborator

Title:	Identification of Novel Molecular Therapeutic Targets in Merkel Cell Carcinoma by Genomic and Proteomic Profiling
Funding Source:	MD Anderson Institutional Grant For Early Career Faculty
Role:	PI

Title:	Analysis of Immunoprofile and Metabolic Signatures in Acral Melanoma
Funding Source:	The University of Texas MD Anderson Cancer Center/Division of Pathology and Lab Medicine
Role:	PI

Title:	A Comparative Analysis of SOX11, CK20, PAX5, and TTF-1 Expressions in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma: Anti-SOX11 as an Effective Discriminatory Immunohistochemical marker for Merkel Cell Carcinoma (Project with mentoring role)
Funding Source:	The University of Texas MD Anderson Cancer Center/Department of Pathology
Role:	PI

Title:	Understanding the Role of Epigenetic Alterations in TERT and Telomerase Activity in Merkel Cell Carcinoma: A Correlation Analysis of TERT Promoter Hypermethylation and TERT Protein Expression and Assessment of Their Prognostic Significance (Project with mentoring role)
Funding Source:	The University of Texas MD Anderson Cancer Center/Division of Pathology and Lab Medicine
Role:	PI

Title:	Molecular study of primary acral lentiginous melanoma from various ethnicities
Funding Source:	IRG
Role:	PI

Title:	Characterization of the Immune Landscape in Acral Lentiginous Melanoma and its Correlation with Patient Outcome and Response to Therapy in Four Different Ethnic Groups (Project with mentoring role)
Funding Source:	The University of Texas MD Anderson Cancer Center/Division of Pathology and Lab Medicine
Role:	PI

Title:	Genomic Analysis of Acral Lentiginous Melanoma in Comparison with UV-Associated Cutaneous Melanoma (Project with mentoring role)
Funding Source:	The University of Texas MD Anderson Cancer Center/Division of Pathology and Lab Medicine
Role:	PI

Title:	Expression of chemokines and other markers in cutaneous adnexal neoplasms (Project with mentoring role)
Funding Source:	Department of Pathology, The University of Texas MD Anderson Cancer Center
Role:	PI

Title:	Acral Lentiginous Melanoma: in the search for biomarkers for prognosis (Project with mentoring role)
Funding Source:	Department of Pathology, The University of Texas MD Anderson Cancer Center
Role:	PI

Title:	Epigenetic Analysis of Acral Lentiginous Melanoma in Comparison with UV-Associated Cutaneous Melanoma (Project with mentoring role)
Funding Source:	Division of Pathology and Lab medicine, The University of Texas MD Anderson Cancer Center
Role:	PI

CV information above last modified November 21, 2024

Phyu P Aung, M.D., Ph.D., F.CAP., F.ASCP

About Dr. Aung

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Selected Publications

Peer-Reviewed Articles

Invited Articles

Manuals, Teaching Aids, Other Teaching Publications

Other Articles

Book Chapters

Letters to the Editor

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Phyu P Aung, M.D., Ph.D., F.CAP., F.ASCP

About Dr. Aung

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Selected Publications

Peer-Reviewed Articles

Invited Articles

Manuals, Teaching Aids, Other Teaching Publications

Other Articles

Book Chapters

Letters to the Editor

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Volunteer